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“Cerebral palsy (CP) describes a group of permanent disorders of the development of movement and 
posture, causing activity limitation, that are attributed to non-progressive disturbances that occurred 
in the developing fetal or infant brain. The motor disorders of CP are often accompanied by distur-
bances of sensation, perception, cognition, communication, behavior, by epilepsy, and by secondary 
musculoskeletal problems.”1
Worldwide, CP is the most common motor disorder in childhood, with a prevalence in Europe 
of about 1.8–2.1 per 1,000 live births.2–5 Within the Dutch pediatric rehabilitation, CP is the largest group 
( > 32%) receiving interdisciplinary pediatric rehabilitation treatments.6 Abnormal motor behavior 
(reflecting abnormal motor control) is the core feature of CP.1
The Surveillance of Cerebral Palsy in Europe (SCPE),7 divides CP into three groups based on the 
predominant neuromotor abnormality; spastic, dyskinetic and ataxic CP.7 By far the largest group 
( > 85%) consists of children with spastic CP.8 This group can be divided in bilateral and unilateral spas-
tic CP. Almost 30% of all the children with CP is diagnosed with unilateral spastic CP (USCP).8
To distinguish on the basis of the severity of the motor impairments of the children with CP, 
several classification systems are used. The Gross Motor Function Classification System–Expanded & 
Revised (GMFCS- E&R) is a 5-level classification system that describes the gross motor function of 
children and youth with CP on the basis of their self-initiated movement with particular emphasis 
on sitting, walking, and wheeled mobility. Distinctions between levels are based on functional abil-
ities, the need for assistive technology, including hand-held mobility devices (walkers, crutches, or 
canes) or wheeled mobility, and to a much lesser extent, quality of movement.9,10
To distinguish between the manual abilities of children with CP, the Manual Ability Classifica-
tion System (MACS) is available. It describes how children with CP use their hands to handle objects 
in daily activities. The five levels are based on the children's self-initiated ability to handle objects and 
their need for assistance or adaptation to perform manual activities in everyday life.11
For both classification systems, a higher number in the classification level means more impairments.
Unilateral Spastic Cerebral Palsy
USCP is characterized by motor impairments lateralized to one side of the body, resulting in an 
“affected” and a “non-affected” body side.7,12,13
In terms of gross- and fine motor functions, children with USCP have quite more possibilities 
compared to other types of CP. Mostly, children with USCP are classified with GMFCS level-I (walks 
without limitations) or level-II (walks with limitations). The difference between these levels is that 
children and youth in level-II have limitations in walking long distances and balancing; may need 
a hand-held mobility device when first learning to walk and may use wheeled mobility when traveling 
long distances outdoors and in the community. Children with GMFCS level-II further require the use 
of a railing to walk up and down stairs and are not as capable of running and jumping, compared to 
children with GMFCS level-I.9
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Concerning the MACS-level, children with USCP are mostly classified with MACS level I (handles 
objects easily and successfully), MACS level-II (handles most objects but with somewhat reduced 
quality and/or speed of achievement) or MACS level-III (handles objects with difficulty; needs help to 
prepare and/or modify activities). In children with USCP, there is no relation between the GMFCS-clas-
sification and MACS-classification.14
Arm hand functioning in children with USCP
Children with USCP are in the functional context, mostly more limited in manual ability than in gross 
motor function.15 They usually have difficulty with grasping, reaching, releasing, and manipulating 
objects with the affected upper extremity (UE).16,17
Children with USCP seldom use their affected UE spontaneously in daily activities.18,19 And 
if they use their affected hand, it will be as an assisting hand. Even with only minor impairment of the 
affected hand, they do not use it to its full potential in bimanual tasks. This lack of spontaneous use is 
referred to as ‘developmental disregard’ or ‘learned non-use’.17
Although many basic activities can be performed with one UE, the performance of numer-
ous complex activities in daily life requires the use of both arms and hands. However, impairments 
in bimanual fine motor function are found in about 60% of the children between the age of 4 and 16 
years.20,21 These impairments in bimanual fine motor function are characterized in particular by difficul-
ties in the spatial and temporal aspects of bimanual coordination22, and these difficulties in planning 
and performing bimanual activities negatively affect the independence, participation and Quality of 
Life of the children with USCP.23 The reduced performance of the affected-UE in children with USCP is 
caused by several factors, like disturbances in passive and active range of motion (ROM), muscle tone, 
sensibility and muscle strength.24–26 Muscle weakness appears to be one of the most important factors 
for the impairments in carrying out UE-activities.24–26
While the performance of the non-affected UE is often assumed to be within expected norms 
of children with typical development, several studies found reduced performance in hand function 
of the non-affected UE, compared to TD-children, e.g. on the Jebsen-Taylor Test of Hand Function, 
on a computerised version of the Peg Moving Task, on the Box and Blocks Test for dexterity and on the 
Tyneside Pegboard Test.27–30
However, whether as in the affected UE, limitation in muscle strength appears to be one of the 
most important factors in this reduced performance, is unknown.
Upper extremity muscle strength in USCP
The muscle strength of the affected UE in children with USCP is typically lower compared to the 
strength of the non-affected UE (up to 64% less muscle strength).31 Compared to the muscle strength 
of TD-children, the affected UE also has reduced muscle strength (up to 84% less muscle strength).32 
Furthermore, compared to their TD-peers, the affected UE of children with USCP 1) is slower in the 
application of force;31,33–35 2) shows sequential force generation;33,36 and 3) has a reduced ability to adjust 
grasping forces to the object’s physical properties.37–40
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Regarding the non-affected UE, only two studies have investigated the muscle strength of the 
non-affected hand in children with USCP, with opposite conclusions. Rich et al. concluded that grip 
strength of the non-affected hand of the children with USCP is on average 12% less compared to 
TD-group.27 However, Tomhave et al. concluded that there are no significant differences when the 
muscle strength of the non-affected hand was compared with norm-values.29 It is therefore unclear 
whether muscle weakness in the non-affected UE exists and when it exists, whether this muscle weak-
ness also exists in the other arm muscles.
Measuring upper extremity muscle strength
The purpose of measuring UE strength can be either discriminative or evaluative. If the goal of the 
measurement is discriminative, the clinician wants to detect the possible existence of muscle weak-
ness. If the goal of the measurement is evaluative, the therapist wants to measure whether changes 
in muscle strength occur, for example as a result of UE muscle strength training or due to the devel-
opment of the child.
Muscle strength is assessed at the body functions level of the International Classification of 
Functioning, Disability and Health for Children and Youth (ICF-CY)41 and several methods are avail-
able to measure muscle strength: dynamic (concentric, eccentric, isotonic and isokinetic) and static 
(isometric).42 During dynamic muscle strength measurements the child needs to cooperate with the 
examiner and perform maximal contractions in one muscle group. Due to spasticity and/or cognitive 
limitations, this is a task that many children with CP find very difficult to perform.43,44 In static/isometric 
muscle strength measurements, the ability of a muscle group to produce force without a change 
in overall muscle-tendon length is measured; therefore, limitations by spasticity (and range of motion) 
will not interfere with task performance during this measurement. Furthermore, in most daily activi-
ties the affected UE is used as an assisting hand (e.g. holding, stabilizing, carrying), and in these tasks 
a high percentage of maximum isometric muscle strength is needed.
For UE muscle strength measurements, the National Institutes of Health Common Data Ele-
ments (NIH-CDE) and the Dutch-guideline “spastic cerebral palsy in children” recommend Maximum 
Voluntary Isometric Contraction Testing, using Hand Held Dynamometers and grip/pinch dynamom-
eter.45,46 There are two methods to measure muscle strength with a Hand Held Dynamometer (HHD); 
the “make method” and the “break method”. During the make method, the child applies maximum 
force against a fixed HHD. With the break method, the force of the examiner exceeds the maximum 
force of the child. In children with spastic CP, the make method is recommended.47
In most daily life manual activities, e.g. during carrying/moving a heavy box, not only a certain 
amount of muscle strength is required, but also the ability to maintain/regulate that strength for 
a certain time.
This ability is called functional strength and it needs to be measured during the performance 
of that specific task.
For children with CP, the “functional strength measurement” (FSM) test exists, measuring both 
lower extremity and UE muscle strength during the performance of functional tasks.48 With this test, 
dynamic maximal muscle strength and submaximal strength during 30 second repetitive measure-
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ments are recorded. Unfortunately, the ability to maintain the maximum functional muscle strength 
in a static sustained contraction cannot be measured with this test. Although the subtests of the FSM 
are functional based, they are also not tailored to relevant activities for children with USCP.
Because of the aforementioned reasons, two specific functional muscle-strength tests measur-
ing unimanual and bimanual sustained contraction, i.e. the “Cup-Task” for determining maximal func-
tional unimanual upper extremity strength, and the “Box-Task” for determining maximal functional 
bimanual upper extremity strength, were developed. In both tests, a combination of functional grip- 
and arm strength is measured by lifting the Box or Cup, which must be sustained for five seconds. In 
a pilot study, both tests were found to be feasible in children with USCP.49 However, extensive research 
into the clinimetric properties has not been performed yet.
Strength training in children with USCP
Although there is no minimum age requirement at which children can begin strength training, all par-
ticipants must be mentally and physically ready to comply with coaching instructions and undergo 
and cope with the stress of a training program; in general this is possible if a child is ready for partici-
pation in sport activities (generally age 7 or 8 years).50 Therefore, intensive strength training programs 
are often applied to children in elementary school.
About the effects of UE-muscle strength training in children with USCP, limited information 
is available. Rameckers et al. performed a critical review of the efficacy of upper limb strengthen-
ing in children with spastic CP.51 Six upper limb strength training studies were found. Two RCTs 52,53 
investigated the effect of stand-alone strength training (not combined with other interventions) of 
the upper limb in children with CP. In both studies small to large positive effects (2.7–58.9%) on mus-
cle strength were reported whereas controls did not show any effects (5.3%). Four studies 54–57 were 
included in which a second intervention was added to the strength training (neuro muscular electro 
stimulation or Botulinum Toxin A). Overall an increase of muscle strength was shown, ranging from 
0.1 to 105% directly after the intervention and from 41.8 to 84.7% at 3 months follow up 54,58, indicating 
a large variability.
Because of the large variability in the results of strength training (and especially in case of small 
improvements), measurement instruments with sound clinimetric properties are needed to properly 
interpret the outcome of such programs.
Clinimetric properties of UE-muscle strength measurement 
instruments for children with USCP
In order to be able to make inferences about muscle strength, either in clinical practice or in research, 
strength has to be measured with an instrument that has sound clinimetric properties, related to 
reliability, validity and responsiveness.
To know to what extent the strength measurement instrument is suitable for discriminative 
and evaluative purposes in clinical practice, the clinimetric properties ‘reliability’ and ‘responsiveness’ 
of the measurement instrument need to be known. The reliability indicates the degree to which 
the measurement is free from the measurement error.59 With the corresponding ICC-value it can be 
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determined whether the measurement instrument is usable for discriminative purposes. The related 
Standard Error of Measurement (SEM) is a measure of how far apart the outcomes of repeated mea-
surements are; it is the standard deviation (SD) around a single measurement.60
Responsiveness indicates the ability of a measurement instrument to detect changes over time 
in the construct to be measured.59 
For the interpretation of a change in score, the Smallest Detectable Change (SDC) and the 
minimally important change (MIC) are important. With the SDC it can be determined whether the 
difference between two (evaluative) measurements can be distinguished from a measurement error. 
In order to know whether a change score is also clinically important, the MIC is considered the most 
important value. The MIC is the smallest change score in the construct to be measured that patients, 
clinicians or relevant others perceive as important.60
The quality of each clinimetric property can be rated as positive, negative or indeterminate, 
according to international accepted criteria.61
Besides sound clinimetric properties, the methodological quality of the study design in which 
the clinimetric properties have been determined is of importance. The COnsensus-based Standards 
for the selection of health Measurement Instruments (COSMIN) is an initiative of an international mul-
tidisciplinary team of researchers with a background in epidemiology, psychometrics, medicine, qual-
itative research, and health care, who have expertise in the development and evaluation of outcome 
measurement instruments. By means of a Delphi study they developed a checklist with which the 
methodological quality of the study design of each clinimetric property can be determined.62 When 
results of the methodological quality and rating of the statistical findings for the individual studies are 
combined, the overall level of evidence for the quality of the clinimetric properties of an instrument 
can be determined. The more studies of good methodological quality that report consistent clinimet-
ric findings, the stronger the level of evidence of the investigated clinimetric property is considered 
to be.61 In studies of excellent methodological quality, the results of clinimetric properties have a high 
level of evidence. In a studies of poor methodological quality, the results of the clinimetric properties 
have an unknow level of evidence rating.63
Due to the unique characteristics of children with USCP, such as disturbances in passive and 
active ROM, muscle tone, sensibility and muscle strength, the clinimetric properties of strength mea-
surement instruments used for children with USCP should be studied specifically within this group.
Scope and outline of this thesis
To get a detailed overview of the existing upper extremity muscle strength tests for children with CP, 
first a systematic review regarding their different clinimetric properties has been performed. Reported 
clinimetric properties were derived from the studies, but also the methodological quality of the 
studies was determined. A data-synthesis of both was performed to determine which measurement 
instruments are useable in clinical practice. (see Chapter 2)
Based on these results, only two instruments were identified as potential useful UE muscle 
strength measurement instruments. Next, the test-retest and interrater reliability of these measure-
ment instruments in children with USCP was investigated, in a study designed using the guidelines of 
the COSMIN consortium (see Chapter 3).
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Because none of the existing measurement instruments measures upper extremity strength 
in the context of functional activities, in which muscle strength must be maintained, we determined 
reliability and validity of two new functional muscle strength measurement instruments in children with 
USCP, also following the guidelines of the COSMIN consortium (see Chapter 4).
As only two studies compared the muscle strength of the non-affected UE of children with USCP 
to TD-children27,29 and had opposite conclusions whether muscle weakness only occurs in the affected 
UE, we performed a study to compare the isometric muscle strength (measured with the HHD and 
E-link) of the non-affected UE of children with USCP to TD-children. (see Chapter 5)
In the last study, we present a critical perspective on how to interpret changes in muscle strength 
as measured with often used measurement instruments for the affected and the non-affected UE, 
taken the minimal important change and the measurement error of the measurement instruments into 
account. (see Chapter 6)
Chapter 7 includes the general discussion, evaluating and integrating the main results. Methodolog-
ical considerations are discussed and implications for clinical practice and future research are presented.
General Introduction
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Abstract
Background. In order to make inferences about strength related to devel-
opment or treatment interventions, it is important to use measurement 
instruments that have sound clinimetric properties.
Purpose. The objective of this review is to systematically evaluate the level 
of evidence of the clinimetric properties of instruments for measuring upper 
extremity muscle strength at the “body functions & structures” level of the 
International Classification of Functioning, Disability and Health for Children 
and Youth (ICF- CY) for children with cerebral palsy (CP).
Data Sources. A systematic search of the PubMed, EMBASE, OTseeker, 
CINAHL, PEDro, and MEDLINE databases up to November 2012 was performed.
Study Selection. Two independent raters identified and examined studies 
that reported the use of upper extremity strength measurement instruments 
and methods for children and adolescents with CP aged 0 to 18 years.
Data Extraction. The COSMIN (COnsensus-based Standards for the selection 
of health status Measurement INstruments) checklist with 4-point rating scale 
was used by 2 independent raters to evaluate the methodological quality of 
the included studies. Best evidence synthesis was performed using COSMIN 
outcomes and the quality of the clinimetric properties.
Data Synthesis. Six different measurement instruments or methods were 
identified. Test-retest, interrater, and intrarater reliability were investigated. 
Two test- retest reliability studies were rated as “fair” for the level of evidence. 
All other studies were rated as “unknown” for the level of evidence.
Limitations. The paucity of literature describing clinimetric properties, espe-
cially other than reliability, of upper limb strength measurement instruments 
for children with CP was a limitation of the study.
Conclusions. For measuring grip strength, the Jamar dynamometer is 
recommended. For other muscle groups, handheld dynamometry is recom-
mended. Manual muscle testing (MMT) can be used in case of limited (below 
MMT grade 4) wrist strength or for total upper limb muscle strength. Based 
on lacking information regarding other clinimetric properties, caution is 
advised regarding interpretation of the results.
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Introduction
The term “cerebral palsy” (CP) describes a group of disorders of the development of movement and 
posture, causing activity limitations that are attributed to non- progressive impairments, that occur 
in the developing fetal or infant brain. Motor disorders in people with CP are often accompanied 
by disturbances of sensation, cognition, communication, perception, or behavior or a seizure disorder, 
or both.1 Abnormal motor behavior (reflecting abnormal motor control) is the core feature of CP. It is 
characterized by various abnormal patterns of movement and posture related to defective coordina-
tion of movements or regulation of muscle tone.2
One of the effects of abnormal motor behavior is the loss of muscle strength. Children with 
CP have less strength in their affected side or sides compared with their peers who are developing 
typically.3–5 Although some studies have focused on the loss of muscle strength in the lower extrem-
ities and evolving impairments of related activities,3,6–8 the decrease in muscle strength of the upper 
extremities also may lead to limitations in activities of daily living, as grip strength is found to be 
a good predictor of use of the affected arm in bimanual performance in children with CP.9,10 To deter-
mine whether strength is a limiting factor in the performance of activities of daily living, it is important 
to measure strength accurately.
Muscle strength is assessed at the body functions level of the International Classification of 
Functioning, Disability and Health for Children and Youth (ICF-CY)11 and can be measured in 3 different 
ways: isometric, isotonic, and isokinetic.12 In order to make inferences about strength, either in clinical 
practice or in research, strength has to be measured with an instrument that has sound clinimetric 
properties. Reliability, for example, is a very important property, among others such as validity and 
responsiveness. One needs to know the degree to which variations in results between repeated mea-
surements occur. This so-called measurement error can arise from several sources: the measurement 
instrument itself, the person or people performing the measurement, the patient undergoing the 
measurement, and the circum- stances under which the measurement is performed.13 The more stud-
ies of good methodological quality that report consistent clinimetric findings, the greater or stronger 
the level of evidence of the investigated clinimetric property is considered to be.14
Several studies have examined clinimetric properties of upper extremity strength measurement 
instruments for children who are developing typically. In most of these studies, test-retest, intrarater, 
and interrater reliability of handheld dynamometers measuring isometric muscle and grip strength 
in the upper extremities in children revealed excellent intraclass correlation coefficients (ICCs).15–21 
Moreover, evaluations of the validity of measurement instruments of isometric upper extremity 
muscle strength in children demonstrated excellent scores.15,16,22 Studies that examined the clinimetric 
properties of lower extremity strength measurement instruments in children with CP revealed moder-
ate to excellent intra- rater and interrater reliability.21,23–27 Studies that examined strength measurement 
instruments for adults with brain damage showed excellent intrasession and intersession, test-retest, 
and intrarater reliability scores for the paretic side.28–30 The nonparetic side showed moderate to excel-
lent intrasession and intersession reliability scores.28
During isotonic and isokinetic muscle strength testing, the patient needs to be able to coop-
erate with the examiner and perform a maximum contraction of one muscle group. This is a task that 
many children with CP find very difficult to perform due to co-contraction of antagonists or agonists 
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or cognitive limitations, or both.31,32 Furthermore, compared with their healthy peers, children with 
CP: (1) are slower in the application of force,4,33–35 (2) show sequential force generation,33,36 (3) have 
a reduced ability to adjust grasping forces to the object’s physical properties,37–40 and (4) have impaired 
motor planning.33,34,41 Children with CP also have impairments in the spatial and temporal aspects of 
bimanual coordination.42 Due to the unique characteristics of children with CP, the clinimetric prop-
erties of strength measurement instruments used for these children should be studied specifically 
in this group.
To our knowledge, no systematic review has been published regarding the different clinimetric 
properties of upper extremity strength measurement instruments for children with CP. The purposes 
of this article are: (1) to systematically review the clinimetric properties of instruments that measure 
upper extremity muscle strength at the “body functions & structures” level of the ICF-CY for children 
with CP and (2) to systematically assess the methodological quality of the clinimetric studies and the 
strength of the evidence provided regarding the clinimetric properties.
Methods
Data Sources and Searches
Electronic searches were conducted in the PubMed, EMBASE, OTseeker, CINAHL, PEDro and, MEDLINE 
databases from the inception of these databases until November 2012. The COSMIN (Consensus-based 
Standards for the Selection of Health Status Measurement Instruments) protocol for the systematic 
review of measurement properties was used to search the PubMed database. According to this proto-
col, the search strategy consisted of collections of search terms for the following characteristics: con-
struct of interest, target population, instrument search, and psychometric properties.43 For construct 
of interest, the following terms were used: Power OR Muscle strength OR Resistance OR Strength OR 
Contraction OR Lift OR “Isometric contraction” OR “Isotonic contraction” OR “Isokinetic contraction” OR 
Grip OR Pinch OR Grasp OR Functional OR Function OR Exercise OR Physical fitness OR Endurance 
OR Tolerance. Target population was defined as: Human AND Child AND (“Cerebral palsy” OR “Muscle 
spasticity” OR Diplegic OR Diplegia OR Monoplegic OR Monoplegia OR Quadriplegic OR Quadriplegia 
OR Spastic OR “Spastic Cerebral Palsies” OR “Unilateral Cerebral Palsy” OR Ataxia OR Atactic OR Disto-
nia OR Distonic OR Hemiplegic OR Hemiplegia) AND (“Upper limb” OR Arm OR Fore-arm OR “Upper 
extremity” OR Shoulder OR Elbow OR Hand OR Wrist OR Finger OR Thumb OR Manual). Because this 
study did not focus on one specific measurement instrument but on all instruments that are used to 
measure upper extremity muscle strength, the instrument search was not defined. All search terms 
were combined with the filter for measurement properties.43 Finally, the exclusion filter (stroke OR 
animals) was added. For the other databases, the above- mentioned words were combined.
Study Selection
Studies of any design that evaluated reliability, validity, or responsiveness were eligible for inclusion. 
Other inclusion criteria were: (1) the study participants were children and adolescents (0–18 years of 
age) with CP; (2) the study examined a measurement instrument or measurement method for upper 
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extremity muscle strength (shoulder/elbow/ wrist/grip) at the “body functions & structures” level of 
the ICF-CY.11 No language restrictions were applied. Studies were excluded if adult patients or children 
without CP were included in the study sample.
After performing the search strategies (K.D.), 2 reviewers (K.D. and E.R.) independently screened 
titles and abstracts for relevance. In cases of no consensus, the opinion of a third reviewer (Y.J.) was 
decisive. Additionally, related articles and the references of the included articles were checked by one 
reviewer (K.D.) for relevance and potential inclusion. These potentially eligible articles were then inde-
pendently screened by the 2 reviewers.
After consensus was reached, full- text reports of the included studies were retrieved and read 
by the 2 reviewers independently. They searched the articles for a clinimetric property of the instru-
ment used to measure upper extremity muscle strength in children with CP.
Data Extraction and Quality Assessment
The extraction and assessment consisted of several steps. First, the descriptive characteristics of the 
sample used in the studies, the procedures used, and the statistical outcomes reported in each study 
were extracted. Second, the methodological quality of the studies was assessed. Third, the quality 
of the clinimetric properties of the measurement instrument was evaluated. Finally, a best evidence 
synthesis was performed.
Rating of Methodological Quality of Individual Studies
Two reviewers (K.D. and E.R.) independently assessed the methodological quality of the included 
studies using the COSMIN protocol. In case of disagreement, discussion with the third reviewer (Y.J.) 
followed until consensus was reached.
To assess methodological quality, the reviewers used the COSMIN checklist with the 4-point 
rating scale, which is recommended for use in systematic reviews of clinimetric properties (www.cos-
min.nl).44 This standardized and validated scoring system was developed based on discussions among 
experts.44 This scoring system allows the overall methodological quality of one clinimetric property 
per study to be calculated. The checklist consists of 9 boxes that each describe a measurement 
property (ie, internal consistency, reliability, measurement error, content validity, structural validity, 
hypothesis testing, cross-cultural validity, criterion validity and responsiveness) and 2 sub- checklists 
to determine the interpretability and generalizability of the study. Each box contains between 5 and 
18 items detailing how each specific clinimetric property should be assessed (see Appendix for the 
example of the reliability box). Each item is scored on a 4-point rating scale (ie, “poor,” “fair,” “good,” or 
“excellent”).44 A methodological quality score is obtained per box by taking the lowest rating of any 
item in that box (“worse score counts”). For our study, in accordance with the COSMIN protocol, only 
the boxes that corresponded to the investigated clinimetric properties were completed. Relevant 
items in the “Interpretability” box and the “Generalizability” box were used as a guide for extracting 
other relevant data from the included studies.
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Rating of Statistical Findings for Individual Studies
One reviewer (K.D.) assessed the quality of the clinimetric properties of the measurement instrument 
in each study by applying widely accepted quality assessment criteria to the statistical outcomes 
(Tab. 1).14 The overall ratings are “good” ( + ), “negative” (—), and “indeterminate” (?).14
Data Synthesis
One reviewer (K.D.) combined the results of the rating of the methodological quality and the rating 
of the statistical findings for the individual studies to determine the overall level of evidence for the 
quality of the clinimetric properties of the identified measurement instruments of upper limb muscle 
strength. This method of synthesizing evidence is similar to the method that is used to synthesize 
evidence from clinical trials.45 The possible levels of evidence are: (1) strong, (2) moderate, (3) limited, 
(4) conflicting, and (5) unknown (Tab. 2).46
Table 1. Rating System for the Statistical Findings for Individual Studies14
Measurement Property Rating Quality Criteria
Internal consistency  + Cronbach alpha ≥.70
— Cronbach alpha < .70
? Cronbach alpha not determined
Reliability  + ICC ≥.70 OR n ≥.70
— ICC < .70 OR n < .70
? Neither ICC nor weighted kappa
Measurement error  + MIC > SDC OR MID > SDC OR MIC outside the LoA
— MIC ≤ SDC OR MID ≤ SDC OR MIC equals or inside LoA
? MIC not defined
Content validity  + The target population considers all items in the questionnaire to be relevant 
AND considers the questionnaire to be complete
— The target population considers items in the questionnaire to be irrelevant 
OR considers the questionnaire to be incomplete
? No target population involvement
Structural validity  + Factors should explain ≥50% of the variance
— Factors explain < 50% of the variance
? Explained variance not mentioned
Hypothesis testing  + Correlation with an instrument measuring the same construct
≥.50 OR ≥75% of the results were in accordance with the hypotheses 
AND correlation with related constructs was higher than with unrelated 
constructs
— Correlation with an instrument measuring the same construct
 < .50 OR < 75% of the results were in accordance with the hypotheses OR 
correlation with related constructs was lower than with unrelated constructs
? Solely correlations determined with unrelated constructs
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Measurement Property Rating Quality Criteria
Cross-cultural validity  + Original factor structure confirmed OR no important DIF between language 
versions
— Original factor structure not confirmed OR important DIF found between 
language versions
? Confirmatory factor analysis not applied and DIF not assessed
Criterion validity (predictive 
or concurrent)
 + Convincing arguments that gold standard is “gold” AND correlation with gold 
standard ≥.70
— Correlation with gold standard < .70 despite adequate design and method
? No convincing arguments that gold standard is “gold” OR doubtful design or 
method
Responsiveness  + Correlation with an instrument measuring the same construct
≥.50 OR at least 75% of the results are in accordance with the hypotheses 
OR AUC ≥0.70 AND correlation with related constructs is higher than with 
unrelated constructs
— Correlation with an instrument measuring the same construct
 < .50 OR < 75% of the results are in accordance with the hypotheses or 
AUC < 0.70 OR correlation with related constructs is lower than with unre-
lated constructs
? Solely correlations determined with unrelated constructs
ICC = intraclass correlation coefficient, n = Cohen (weighted) kappa, SDC = smallest detectable change, MIC = minimal important change, 
MID = minimal important difference, LoA = limits of agreement, DIF = differential item functioning, AUC = area under the receiver operating 
characteristic curve, +  = positive rating, — = negative rating, ? = indeterminate rating
Table 2. Synthesis of Study Quality and Findings 46
Level Rating Criteria
Strong evidence  +  +  + or ——— Consistent findings in multiple studies of good methodological quality 
or in one study of excellent methodological quality
Moderate evidence  +  + or —— Consistent findings in multiple studies of fair methodological quality or 
in one study of good methodological quality
Limited evidence  + or — One study of fair methodological quality
Conflicting evidence ± Conflicting findings
Unknown evidence ? Only studies of poor methodological quality
 +  = positive rating, — = negative rating, ± = conflicting rating, ? = indeterminate rating.
Results
Study Selection
The selection procedures are summarized in the Figure. Seven eligible studies were identified, and 3 
types of reliability (ie, intrarater, interrater, and test-retest) in 6 different measurement instruments were 
studied. The measurement instruments and methods used were: (1) manual muscle testing (MMT), 
(2) the Jamar dynamometer, (3) a handheld dynamometer (HDD), (4) an instrument based on muscle 
strength torque sensors, (5) a computerized measurement tool using a strain gauge, and (6) a modified 
sphygmomanometer. A more detailed description of the included studies is given in Table 3.
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MMT. Klingels et al.47 investigated interrater reliability and test-retest reliability of MMT of shoulder 
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.96 were found. For interrater reliability, ICC values varied between .60 and .91. 
 
Jamar dynamometer. Klingels et al.47 investigated test-retest and inter- rater reliability of isometric grip 
strength of the upper extremity in children with CP using the Jamar dynamometer. Intraclass correlation 
coefficients of .96 and .95 were found for test-retest and interrater reliability, respectively. 
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MMT. Kling ls et al.47 i vestigated in errater r liability nd test-ret t reliability of MMT of shoul-
der flexion, abduction, and adduction; elbow flexion and extension; fore- arm supination and prona-
tion; and wrist flexion and extension in children with CP. For test-ret st reliability, ICC values between 
.88 and .96 were found. For interrater reliability, ICC values varied between .60 and .91.
Jamar dynamometer. Klingels et al.47 investigated test-retest and inter- rater reliability of isomet-
ric grip strength of the upper extremity in children with CP using the Jamar dynamometer. Intraclass 
correlation coefficients of .96 and .95 were found for test-retest and interrater reliability, respectively.
HHD. Crowner and Racette48 investigated test-retest reliability of the MicroFET HHD (Hoggan 
Health Industries Inc, Draper, Utah) for testing muscle strength of the shoulder and elbow muscles 
and the Baseline hydraulic HHD (FEI, Irving- ton, New York) for assessing grip strength. Vaz et al.5 
used a MicroFET2 HHD for investigating the test-retest reliability of muscle strength testing of 
the wrist flexors and extensors. In the study by Crowner and Racette,48 a total score of .99 was 
mentioned without indicating what the score means or how it was calculated. In the study by Vaz 
et al,5 ICC values between .93 and .98 were found for test-retest reliability of measurements of wrist 
flexion and extension.
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Muscle strength-torque sensors. In the study by Bleyenheuft et al,49 test-retest reliability of isomet-
ric fingertip grip muscle strength and load muscle strength was investigated. No significant difference 
was found between the first and second measurements (P = .935).
Strain gauge technology. Rameckers et al.50 investigated test- retest reliability of maximum vol-
untary contraction (MVC) of the index flexor muscles. Intraclass correlation coefficient values of .99 
were found for the finger and wrist flexors.
Sphygmomanometry. Glazier et al.51 investigated test-retest reliability and Xu et al.52 investigated 
intrarater reliability of grip strength measurements using a modified sphygmomanometer. Glazier et 
al51 found a Pearson correlation coefficient of .97 for test-retest reliability and Xu et al52 reported an ICC 
value of .919 for intrarater reliability of grip strength measurements.
Rating of Methodological Quality of Individual Studies
For all 6 instruments, the COSMIN box for reliability could be completed to rate the methodological 
quality of the corresponding studies. Most studies were rated as “poor” for methodological quality. The 
studies of interrater reliability of MMT47 and Jamar dynamometer47 measurements were rated as “fair” 
for methodological quality (Tab. 4). According to the guidelines in the COSMIN manual,53 the other 
boxes could not be completed.
Rating of Statistical Findings for Individual Studies
The quality of the clinimetric properties was assessed for all 6 instruments (Tab. 4). Most clinimetric 
properties were rated as “good.” Interrater reliability of shoulder and elbow measurements obtained 
with MMT was rated as “poor.” Test-retest reliability of total upper extremity HHD measurements and 
of measurements of grip strength obtained with the modified sphygmomanometer were scored as 
“indeterminate” because no justified statistical method was used.
Data Synthesis
The results of the methodological quality assessment and the quality assessment of the clinimetric 
proper- ties were combined and are presented in Table 5. For most of the instruments, the level of evi-
dence was rated as “unknown.” For upper extremity/wrist strength measurements with MMT and grip 
strength measurements with the Jamar dynamometer, the level of evidence was rated as “limited,” 
with a positive rating of the clinical property. For shoulder/elbow muscle strength measurements 
with MMT, the level of evidence is rated as “limited,” with a negative rating of the clinical property.
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Table 5. Levels of Evidence of Upper Extremity Strength Measurement Instruments
Measurement Instrument  
or Method
Measurement Property
Interrater Reliability Test-Retest Reliability
Intrarater  
Reliability
MMT  + (upper extremity/wrist)
— (shoulder/elbow)
? (upper extremity/shoulder/ 
elbow/wrist)
0
Jamar dynamometer  + (grip) ? (grip) 0
HHD 0 ? (upper extremity/wrist) 0
Muscle strength-torque sensor 0 ? (upper extremity) 0
Strain gauge technology 0 ? (index finger flexor 
strength)
0
Modified sphygmomanometer 0 ? (grip) ? (grip)
MMT = manual muscle testing, HHD = handheld dynamometer, +  = limited positive evidence, — = limited negative evidence, ? = unknown 
evidence, 0 = no evidence.
Discussion
The purpose of this systematic review was to study the clinimetric properties of upper extremity 
strength measurement instruments used for children with CP. This review clearly exposes the lack 
of adequate studies investigating clinimetric properties of upper extremity strength measurement 
instruments for children with CP.
In the few studies using measurement instruments of upper extremity strength, only test-retest, 
intrarater, and interrater reliability were investigated in a select group of age ranges, Manual Ability 
Classification system (MACS) levels,54 and Gross Motor Function Classification System (GMFCS) levels.55 
No conclusions can be made regarding the possibility of determining changes over time (responsive-
ness), the smallest detectable change (SDC), or the standard error of measurement (SEM). Further-
more, it is not clear whether all of the measurement instruments specifically measure muscle strength, 
as validity has not been investigated. Therefore, more research on the other clinimetric properties 
must be done for all of the instruments before they are used in clinical practice or further studies.
Only 2 of the studies47,51 were specifically designed to assess the clinimetric properties of the 
measurement instruments. All of the other studies were intervention studies, necessitating a reliability 
study of the outcome measurement. These findings may explain why only test- retest, interrater, and 
intrarater reliability are investigated in mostly small groups of children.
None of the measurement instruments were rated as “strong” or “moderate” for the level of evi-
dence. According to the COSMIN standards, only the studies that reported on the interrater reliability 
of the MMT47 and Jamar dynamometer47 were rated as “fair” for methodological quality; therefore, the 
level of evidence was rated as “limited.”
In MMT, interrater reliability of muscle strength measurements of the shoulder and elbow 
had poor statistical outcomes. Manual muscle testing, therefore, is not recommended for measuring 
muscle strength in these muscle groups. Only the total upper extremity MMT score and the score of 
the wrist muscles had good interrater reliability. Although MMT is commonly used in clinical practice, 
its use is dissuaded with other populations described in the literature,56,57 despite the findings of 
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Klingels et al.47 The studies by Noreau and Vachon56 and Schwartz et al.57 showed there is wide 
variability in grading values with MMT grades 4 and 5. Therefore, it is recommended that MMT be 
used in the positive-rated muscle groups (upper extremity total, wrist) in children with less muscle 
strength (≤ grade 3).
The Jamar dynamometer had good statistical outcomes and, therefore, is recommended for 
measuring grip strength in children with CP. The positive characteristics of the Jamar dynamome-
ter are that it is a small device (handheld, lightweight [1.4 kg]) that is relatively inexpensive (retail 
price = $300) and easy to use. The negative characteristics of the Jamar dynamometer are that it can 
only be used to measure handgrip strength, and it cannot be used by children with very small hands. 
Moreover, the range (0–90 kg) and incremental 2-kg steps may not be suitable to measure minimal 
changes, especially for young or small children or for children with very poor muscle strength. Based 
on these results, the Jamar dynamometer appears to have good potential as a reliable and clinically 
useful instrument for measuring handgrip strength in children with CP. However, specific assessment 
of its clinimetric properties in children with CP is warranted.
According to the COSMIN standard, all of the other studies had poor methodological quality; 
therefore, the levels of evidence of all other studies were rated “unknown.” The poor methodological 
quality is partly due to the fact that all of the studies used rather small sample sizes to investigate the 
clinimetric properties of the strength measurement instruments. Sample sizes varied between 2 and 
30 people. The COSMIN manual53 recommends a minimum sample size of 50, although a sample size 
of 100 would be better. Pooling data to achieve these sample sizes was not possible. Because of the 
unknown level of evidence, the outcomes of these clinimetric properties must be interpreted with 
extra care.
Although the levels of evidence for the other measurement instruments and methods (ie, HHD, 
muscle strength-torque sensors, strain gauge technology, and modified sphygmomanometer) were 
rated as “unknown,” the clinimetric properties were rated as “good” or “indeterminate.” Therefore, for 
some of these instruments, a sufficient level of evidence can be reached when the clinimetric prop-
erties are researched in studies of good or excellent methodological quality. In order to consider their 
clinical applicability, the positive and negative characteristics of these instruments will be described.
The positive characteristics of the MicroFET 2 dynamometer are that it is a small device (hand-
held, weighs less than 0.5 kg) that is relatively inexpensive (retail price = $1,095) and easy to use. 
Moreover, its ability to detect small changes might be good because of the small incremental steps 
of 1 N·m. The negative characteristics of the Microfet 2 dynamometer are that the assessor can have 
difficulty stabilizing the patient while using the device, the opposing strength of the examiner poten-
tially contributes to the measured force, and inaccurate readings can be made when the force is not 
applied in a precise, perpendicular direction.58 In addition, different protocols are used worldwide, and 
various articles have already identified the need for further research and development of standard-
ized handheld dynamometry procedures in children with CP.23–25 Studies researching the reliability 
of handheld dynamometry of the lower extremities in children with CP showed intrarater reliability 
(ICC) scores between .38 and .96 for the lower leg muscles in a sample of 10 to 25 children with CP.21,23–27 
Interrater reliability of handheld dynamometry of the lower extremities in children with CP varies 
between .39 and .94, depending on the muscle group and method of measuring.21,23 The results of 
these studies are similar to those found in the studies on the upper extremities: low sample sizes and 
Upper Extremity Strength Measurement for Children with Cerebral Palsy: A Systematic Review of Available Instruments
37
2
mild to good reliability. When combined, these findings indicate that the MicroFET 2 dynamometer 
has potential as a reliable instrument for measuring upper limb muscle strength in children with CP. 
Future research should focus on all clinimetric properties of the HHD with regard to measuring the 
strength of the upper extremities of children with CP.
The positive characteristics of muscle strength-torque sensors and strain gauge technology 
are that the outcomes are computerized and show small incremental steps (because high-quality 
strain levers were used). Therefore, they can be very accurate. In addition, errors caused by inaccurate 
reading of the display by the examiner can be pre- vented by storing the outcome digitally, which can 
improve the reliability. Because of the small increments shown on the display, the outcomes of the 
modified sphygmomanometer are very accurate. A disadvantage of these instruments is that they are 
specially designed for research purposes. These instruments are not commercially or broadly available 
and, therefore, are more difficult to implement in daily clinical practice.
Limitations
The COSMIN method is a strict method with stringent rules, and it sets high standards for method-
ological design of clinimetric studies and reporting. The COSMIN standards were originally developed 
for evaluating questionnaire-based measurement instruments. One of the stringent rules is a mini-
mum of 50 included samples in the study to achieve good methodological quality. For most studies 
that focus on clinimetric properties of questionnaire-based measurement tools, it is easier to adhere 
to this standard compared with studies that focus on clinimetric properties of performance-based 
measurement tools. Therefore, it is possible that the COSMIN standards have limitations when evalu-
ating measurement tools that are performance-based.
In most studies included in the present review, the lack of information on their design and other 
important items of the COSMIN checklist is highly remarkable. Information about the COSMIN items 
of “missing data” (the percentage of missing data), “how missing items were handled,” and “indepen-
dent administrations” (assessors blinded) often was absent. Also, the standard of the included sample 
size in the analysis often was not adequate. Because of this missing information and the small sample 
sizes, subitems automatically were given a low score in the COSMIN box. Furthermore, because of 
the limited number of studies that described clinimetric properties, it was not possible to compare 
studies and provide an overall conclusion of the best measurement instrument.
Conclusion and Recommendations
Although several instruments for measuring upper extremity strength in children with CP are avail-
able, research on the clinimetric properties of these instruments is rarely done. To measure grip 
strength, it is recommended to use the Jamar dynamometer. For measuring other upper extremity 
muscle groups, it is recommended to use the HHD. Manual muscle testing can be used when 
measuring total upper extremity or wrist strength in children with CP who have very limited mus-
cle strength (below grade 4). However, caution with interpretation of the test results is warranted 
because no information is available regarding the possibility of determining changes over time 
(responsiveness), the SDC, the SEM, and the validity of these instruments. Future studies should be 
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designed according to the COSMIN criteria; should go beyond interrater, intrarater, and test-retest 
reliability; and should be performed on children with CP from different age groups and all MACS 
levels,54 according to a well-described protocol.
All authors provided concept/idea/research design, writing, and data analysis. Mr Dekkers, 
Dr Rameckers, and Dr Janssen-Potten provided data collection. Dr Smeets provided project 
management, fund procurement, facilities/equipment, and institutional liaisons. Dr Smeets and 
Dr Janssen-Potten provided consultation (including review of manuscript before submission). The 
authors are grateful to Krys Galama and Maria Kamphuis for correcting the English text.
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Appendix. Example of COSMIN (COnsensus-based Standards for the selection of health status Mea-
surement INstruments) Measurement Property Box 57
Box B. Reliability: relative measures (including test-retest, interrater, and intrarater reliability)
Excellent Good Fair Poor
Design requirements
1 Was the percentage 
of missing items 
given?
Percentage of miss-
ing items described
Percentage of 
missing items not 
described
2 Was there a descrip-
tion of how missing 
items were handled?
Described how 
missing items were 
handled
Not described but 
how missing items 
were handled can be 
deduced
Not clear how 
missing items were 
handled
3 Was the sample 
size included in the 
analysis adequate?
Adequate sample 
size (≥100)
Good sample size 
(50–99)
Moderate sample size 
(30–49)
Small sample size 
( < 30)
4 Were at least 2 mea-
surements available?
At least 2 measure-
ments
Only 1 measurement
5 Were the administra-
tions independent?
Independent mea-
surements
Assumable that the 
measurements were 
independent
Doubtful whether 
the measurements 
were independent
Measurements not 
independent
6 Was the time interval 
stated?
Time interval stated Time interval not 
stated
7 Were patients stable 
in the interim period 
on the construct to 
be measured?
Patients were stable 
(evidence provided)
Assumable that 
patients were stable
Unclear whether 
patients were stable
Patients were not 
stable
8 Was the time interval 
appropriate?
Time interval appro-
priate
Doubtful if time 
interval was appro-
priate
Time interval not 
appropriate
9 Were the test 
conditions (eg, type 
of administration, 
environment, instruc-
tions) similar for both 
measurements?
Test conditions were 
similar (evidence 
provided)
Assumable that test 
conditions were 
similar
Unclear if test condi-
tions were similar
Test conditions were 
not similar
10 Were there any 
important flaws 
in the design or 
methods of the 
study?
No other important 
methodological 
flaws in the design 
or execution of the 
study
Other minor method-
ological flaws in the 
design or execution 
of the study
Other important 
methodological 
flaws in the design 
or execution of the 
study
Statistical methods
11 For continuous 
scores: Was an 
intraclass correlation 
coefficient (ICC) 
calculated?
ICC calculated and 
model or formula of 
the ICC is described
ICC calculated but 
model or formula of 
the ICC not described 
or not optimal.
Pearson or Spearman 
correlation coefficient 
calculated with 
evidence provided 
that no systematic 
change has occurred.
Pearson or Spearman 
correlation coefficient 
calculated without 
evidence provided 
that no systematic 
change has occurred 
or with evidence that 
systematic change 
has occurred.
No ICC or Pearson or 
Spearman correla-
tions calculated
12 For dichotomous/
nominal/ ordinal 
scores: Was kappa 
calculated?
Kappa calculated Only percentage of 
agreement calculated
13 For ordinal scores: 
Was a weighted 
kappa calculated?
Weighted kappa 
calculated
Unweighted kappa 
calculated
Only percentage 
agreement calculated
14 For ordinal scores: 
Was the weighting 
scheme (eg, linear, 
quadratic) described?
Weighting scheme 
described
Weighting scheme 
not described
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Abstract
Purpose: To investigate test–retest and inter-rater reliability of maximum 
isometric arm muscle strength measurements using the hand-held dynamo-
meter (HDD) and maximum isometric grip and pinch strength measurements 
using the Biometrics E-Link Evaluation System in children aged 7–12 years with 
unilateral spastic cerebral palsy.
Materials and methods: All data were obtained using a test–retest study 
design. The study met the conditions of the COSMIN criteria to achieve good 
methodological quality.
Results: For arm strength measurements, all test–retest reliability intraclass 
correlation coefficient (ICC) values and all but one inter-rater reliability ICC 
value indicated excellent reliability. For grip- and pinch strength measure-
ments, all test–retest reliability and inter-rater reliability ICC values showed 
excellent reliability. The standard error of measurement values ranged from 
4.97 to 11.36 N (HDD) and 0.37 to 1.81 kg (E-link). Smallest detectable change 
values ranged from 13.79 to 31.49 N (HDD) and 1.03 to 5.02 kg (E-link).
Conclusions: The HDD and E-link system are usable measurement instru-
ments for cross-sectional muscle strength measurements in children with 
unilateral spastic cerebral palsy. It is not clear if both instruments are usable to 
measure changes in muscle strength within an individual, especially if a child 
with unilateral spastic cerebral palsy has low muscle strength. Caution in the 
interpretation of changes in muscle strength is therefore necessary.
IMPLICATIONS FOR REHABILITATION
 — The hand-held dynamometer and E-Link Evaluation System are reliable 
measurement instruments to measure muscle strength of the arm and 
hand in children with unilateral spastic cerebral palsy, aged 7–12 years.
 — Cross-sectional measurements; it is possible to measure upper extrem-
ity muscle strength in children with unilateral spastic cerebral palsy 
with the hand-held dynamometer and E-link system.
 — Longitudinal measurements; changes in upper extremity muscle 
strength within one person should be interpreted with care, especially 
if a child with unilateral spastic cerebral palsy has low muscle strength.
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Introduction
Abnormal gross and fine motor functioning and organization (reflecting abnormal motor control) 
are the core features of unilateral spastic cerebral palsy (USCP).1 In children with USCP, the muscles 
of the affected upper extremity (UE) are typically weaker than those of the contralateral UE and the 
strength of the UE of typically developing peers.2–4 Muscle weakness of the UE may lead to limitations 
in daily activities, as grip strength has shown to be an important predictor of use of the affected arm 
in bimanual performance in children with USCP.5,6
Muscle strength in children with USCP could be measured for different reasons. Sometimes one 
needs to know if muscle strength could contribute to problems carrying out activities of daily living. 
Another reason could be if a therapist wants to know if muscle strength is gained after a strength 
training program. Strength training programs are recommended starting at 7 years of age.7 Intensive 
strength training programs are often delivered to children in elementary school.
Several methods are available to measure muscle strength: dynamic (concentric, eccentric, 
isotonic, and isokinetic) and static (isometric). Dynamic muscle strength measurements may be 
influenced by spasticity as well as by limitations in the range of motion of the UE. In static/isometric 
muscle strength measurements, the ability of a muscle group to produce force without a change 
in overall muscle-tendon length is measured; therefore, limitations by spasticity and range of motion 
will not interfer with task performance during this measurement. Furthermore, in most daily activities 
the affected UE is used as an assisting hand (e.g., holding, stabilizing, carrying), and in these tasks 
a high percentage of maximum isometric muscle strength is needed.
(Isometric) muscle strength must be measured accurately; therefore, the instrument should 
have sound clinometric properties. A recent systematic review on the clinometric properties of 
measurement instruments for measuring UE strength in children with USCP concluded that research 
on clinometric properties is rarely conducted, and caution is needed regarding interpretation of the 
test results. Only reliability has been studied, and most of the available studies were of poor method-
ological quality.8 Future studies should be designed according to the Consensus- based Standards for 
the selection of health Measurement INstruments (COSMIN) criteria and should use a well-described 
protocol. The hand dynamometer is recommended for measure- ment of grip strength. For measur-
ing other UE muscle groups, it was recommended that the hand-held dynamometer (HDD) be used.8 
Reliability is an important clinometric property. One needs to know the degree to which variations 
in measurement appear when no changes in the disease or disorder have occurred. This so-called 
measurement error can arise from several sources: the measurement instrument itself, the person(s) 
assessing the measurement, the patient undergoing the measurement and the circumstances under 
which the measurement is performed.9 Two important components of reliability are the standard 
error of the measurement (SEM) and smallest detectable change (SDC).9 The SEM is a measure of 
how far apart the outcomes of repeated measurements are; it is the standard deviation (SD) around 
a single measurement.9 The SDC is the smallest change in score that you can detect with the instru-
ment, above measurement error in individual patients.9 To date, no data on SEM and SDC of the hand 
dynamometer and HHD in children with USCP are available in literature.
Reliability of maximum isometric arm, grip and pinch strength measurements in children (7–12 years) with unilateral spastic cerebral palsy
49
3
The purpose of this paper is to investigate the test–retest and inter-rater reliability (including 
SEM and SDC) of maximum isometric arm strength (IAS) measurements using the HHD and maximum 
isometric grip and pinch strength (IGPS) measurements using the Biometrics E-Link Evaluation System 
(digitalized hand- dynamometer), in children with USCP in a study of good methodological quality 
according to the COSMIN criteria.10
Materials and methods
Study design
All data were obtained using a test–retest study design. Data were collected in the Netherlands and 
USA, from 2009 to 2016.
Participants
Permission was granted by the Medical Ethical Board of the Maastricht University Medical Center 
and Maastricht University (METC azM/UM) in the Netherlands and at Teachers College, Columbia 
University in New York City, USA. In the Netherlands, the children were recruited from four dif-
ferent rehabilitation centres and related schools for special education, i.e., Adelante Rehabilitation 
Centre, Valkenburg, Libra Rehabilitation and Audiology, Tilburg, Revant Rehabilitation Centers, 
Breda and Goes, and Tolbrug Rehabilitation Centre, Den Bosch. In the USA, participants were 
a convenience sample of children participating in ongoing intensive UE studies at Teachers 
College, Columbia University.
This study focused on children with predominantly USCP between 7 and 12 years of age. The 
diagnosis USCP was based on the classification used by the child’s neurologist or paediatrician. They 
were classified as Gross Motor Function Classification System (GMFCS)11 I–II and Manual Ability Classi-
fication System (MACS)12 levels I, II, or III. All participants were capable of following simple instructions. 
A child was excluded when he/she had undergone surgery or Botulinum Toxin-A treatment in the 
UE in the past 6 months. A child was excluded from the test–retest reliability measurements if he/she 
was participating in an intensive UE training program between the two measurements. There was no 
minimum muscle strength required to participate.
Procedure
Children were tested at the location from where they were recruited. A standardized protocol, with 
detailed descriptions of all procedures and measurements, was used (see Supplementary material). 
Prior to testing, body weight, MACS12 and GMFCS11 level were determined.
In USCP it is stated that increased muscle tone and weakness are most pronounced in distal mus-
cle groups.6 Accordingly, we decided to only test elbow, wrist and hand (grip/pinch) strength. In each 
child, a pre-randomized mix of measurements, using the random.org app (mobile application software)13 
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was used. Each measurement was performed three consecutive times. Between each measurement, the 
child had at least 30 seconds of rest to allow for muscle recovery. In each test, both the affected hand (AH) 
and the non-affected hand (NAH) were measured. The NAH was tested before the AH.
For each measurement, the child was seated in an upright position in a chair with back support 
and armrests. For all measurements, the armrests of the chair were used to support the arms during 
testing. The initial posture was neutral position (0°) of the wrist joint and 90° flexion of the elbow joint.
With the HHD, isometric wrist extension with stretched fingers, wrist extension with flexed fin-
gers, wrist flexion with stretched fingers and elbow flexion/extension were measured. With the E-Link 
Evaluation System, IGPS were measured. The handle position of the E-link handgrip was adapted to the 
child’s hand size, according to the E-link guideline for positioning. The child was also asked whether 
the position of the handle felt the best. When there was doubt, other handle positions were tried.
Test scores were read by the therapist and registered by the same therapist on a test form. For 
the E-Link Evaluation System, test scores were also stored on the E-Link Evaluation System computer. 
Children were verbally encouraged by the therapist to produce maximum force, by saying “hard, 
harder, hardest” in a time span of 4–5 seconds.
To evaluate test–retest reliability, the standardized protocol was conducted two times by the 
same therapist within 2–4 weeks. This time interval was chosen because during normal development 
(without intensive UE training) no muscle strength loss or gain was expected, and the possible 
motivation/influence of the therapist/child to score the same result as during the first measurement 
(because the first result could be remembered by the child/therapist) was minimal. For the second 
time, test conditions were kept identical.
To evaluate inter-rater reliability, the standardized protocol was conducted two times on the 
same day, by two different therapists. There was approximately 30 minutes of rest between each 
assessment. This rest period was judged sufficient for the child to recover and limited the possibility 
for personal and environmental factors to change.
All measurements were performed by eight (paediatric) physical therapists, who had no direct 
professional connection with the participants. All the therapists performed the measurements in the 
Netherlands. Two of them also performed the measure- ments in the USA. They had four hours of 
training by an experienced paediatric physical therapist on how to use the standardized protocol 
in children with USCP.
Measures
Isometric arm strength
Maximum IAS was measured with the Microfet 2 HHD (Hoggan Scientific, LLC, Salt Lake City, UT). 
An HHD is an electronic device that fits in the palm of a hand. A load cell (strain gauge technology) 
measures the isometric muscle strength applied to a transducer. The “make method”, in which the 
child applies force against a fixed HHD, was used.14 The applied force was measured in Newtons.
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Isometric grip and pinch strength
Maximum IGPS of both AH and NAH were measured with the Biometric E-Link Evaluation System 
(Biometrics Ltd, Gwent, UK). As lateral pinch/key pinch is the easiest in children with USCP, this pinch 
position was chosen. The E-Link Evaluation System is a calibrated, computerized system incorporating 
a modified (digitalized) grip dynamometer and a pinch meter. The applied force was measured in 0.1 kg.
Statistical analysis
For each test, the mean of three measurements was calculated. In this way, variability in muscle 
strength due to variations in placing the measurement instrument on a prescribed measurement spot 
(and therefore a smaller or larger torque arm) was minimized. Intraclass correlation coefficients (ICC), 
model two way random, type absolute agreement, with a 95% confidence interval (CI) were used to 
assess test–retest reliability and inter-rater reliability. An ICC > 0.80 reflects excellent reliability, while 
ICCs from 0.70 to 0.79 reflect good reliability.15
The SEM agreement was calculated as the square root of the error variance (including the sys-
tematic error).9 The SDC was computed as 1.96 multiplied by the square of 2, multiplied by the SEM 
(SDC = 1.96 x √2 x SEM).9
Results
A total of 86 children (53 boys, 33 girls; mean age 9 years, 3 months, SD 1 year 8 months) with USCP 
participated in this study. Their parents (and children aged 12 years) provided informed consent for 
participation. Due to the availability of the child and/ or measurement instrument or because the 
child met the exclusion criterion for the test–retest reliability study, some children only performed 
the measurements of the test–retest reliability and some only the measurements of the inter-rater 
reliability. Therefore, the sample sizes vary across the measurements. Participant characteristics per 
measurement are provided in Table 1.
Test–retest reliability
For the IAS, 52 children performed all measurements. For the IGPS, the total number of participants 
was 65. There were no missing items. The test–retest reliability statistics of the IAS and IGPS are pre-
sented in Table 2.
Affected hand
Test–retest ICC values for the IAS measurements varied between 0.887 (CI 0.799–0.936) for the elbow 
extension and 0.964 (CI 0.938–0.979) for the wrist extension. ICC values for the IGPS measurements 
were 0.940 (CI 0.896–0.965) for pinch strength and 0.948 (CI 0.914–0.968) for grip strength. For the IAS, 
the SDC was 13.79 N for wrist extension and 31.49 N for elbow extension. For the IGPS, the SDC was 1.03 
kg for pinch strength and 3.47 kg for grip strength.
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Non-affected hand
ICC values for the IAS measurements varied between 0.888 (CI 0.806–0.936) for wrist extension with 
flexed fingers and 0.973 (CI 0.952–0.984) for elbow extension. For the IGPS measurements, ICC values 
were 0.937 (CI 0.895–0.962) for pinch strength and 0.942 (CI 0.904–0.964) for grip strength. The SDC for 
the IAS was 24.54 N for wrist extension with stretched fingers and 30.89 N for wrist flexion. For the IGPS, 
the SDC was 1.41 kg for pinch strength and 5.02 kg for grip strength.
Table 1. Participants characteristics.
Measurement Characteristics
Test-retest reliability study
Total group Age group Gender mix
Isometric Arm Strength measurements 
(HHD)
n = 52. 33♂. 19♀.
Mean age 9.3 years. SD 1.9 years.
35 right side affected. 17 left side affected
MACS level; I: n = 16. II: n = 28. III: n = 4. 
missing n = 4
Age 7. n = 13 6♂. 7♀
Age 8. n = 10 4♂. 6♀
Age 9. n = 7 5♂. 2♀
Age 10. n = 5 4♂. 1♀
Age 11. n = 6 5♂. 1♀
Age 12. n = 11 9♂. 2♀
Isometric Grip and pinch strength measure-
ments (E-link system)
n = 65. 41♂. 24♀.
Mean age 9.2 years. SD 1.8 years.
40 right side affected. 25 left side affected
MACS level; I: n = 21. II: n = 33. III: n = 7. 
missing n = 4
Age 7. n = 15; 7♂. 8♀
Age 8. n = 12 5♂. 7♀
Age 9. n = 12 7♂. 5♀
Age 10. n = 5 4♂. 1♀
Age 11. n = 10 9♂. 1♀
Age 12. n = 11 9♂. 2♀
Inter-rater reliability study
Total group Age group Gender mix
Isometric Arm Strength measurements 
(HHD)
n = 53. 31♂. 22 ♀.
Mean age 9.0 years. SD 1.7 years.
31 right side affected. 22 left side affected
MACS level; I: n = 15. II: n = 29. III: n = 4. 
missing n = 5
Age 7. n = 14 8♂. 6♀
Age 8. n = 11 4♂. 7♀
Age 9. n = 9 7♂. 2♀
Age 10. n = 8 5♂. 3♀
Age 11. n = 3 2♂. 1♀
Age 12. n = 8 5♂. 3♀
Isometric Grip and Pinch Strength measure-
ments (E-link system)
n = 54. 31♂. 23 ♀.
Mean age 9.0 years. SD 1.7 years
31 right side affected. 22 left side affected
MACS level; I: n = 15. II: n = 29. III: n = 5. 
missing n = 5
Age 7. n = 14 8♂. 6♀
Age 8. n = 11 4♂. 7♀
Age 9. n = 10 7♂. 3♀
Age 10. n = 8 5♂. 3♀
Age 11. n = 3 2♂. 1♀
Age 12. n = 8 5♂. 3♀
Abbreviations: HHD = hand held dynamometer; ♂ = male; ♀ = female; SD = standard deviation; n = population size; MACS = Manual Ability 
Classification System
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Inter-rater reliability
For the IAS, 53 children performed all measurements. For the IGPS, the total number of participants 
was 54. The inter-rater reliability statistics of the IAS and IGPS are presented in Table 3. There were no 
missing items.
Affected hand
Inter-rater ICC values for the IAS measurements varied between 0.799 (CI 0.652–0.883) for elbow exten-
sion and 0.963 (CI 0.932–0.980) for wrist extension. For the IGPS measurements, ICC values were 0.964 
(CI 0.938–0.979) for pinch strength and 0.976 (CI 0.959–0.986) for grip strength. The SDC for the IAS 
was 14.59 N for wrist extension and 32.21 N for elbow flexion. The SDC for the IGPS was 1.19 kg for pinch 
strength and 3.65 kg for grip strength.
Non-affected hand
ICC values for the IAS measurements varied between 0.878 (CI 0.789–0.930) for wrist extension and 
0.942 (CI 0.899–0.967) for elbow extension. ICC values for the IGPS measurements were 0.960 (CI 
0.932–0.977) for grip strength and 0.967 (CI 0.943–0.981) for pinch strength. The SDC for the IAS was 
23.80 N for wrist flex- ion and 32.13 N for elbow flexion. For the IGPS, the SDC was 1.51 kg for pinch 
strength and 5.28 kg for grip strength.
Discussion
The purpose of this study was to investigate the reliability of maximum isometric UE strength mea-
surements in children aged between 7 and 12 years with USCP using the HHD, and maximum IGPS 
measurements using the Biometric E-Link Evaluation System, in a high-quality study designed accord-
ing to the COSMIN criteria.10
For the IAS measurements in this study, all test–retest reliability ICC values and all inter-rater 
reliability ICC values, except elbow flexion of the AH, indicated excellent reliability, which is in line with 
those previously reported by Crowner and Racette16 and Vaz et al.4 However, assessment of the clino-
metric properties of the HDD was not the main goal of these studies. This could explain their small 
sample sizes and the limited description of the design of the reliability study. In both studies, infor-
mation about GMFCS11 and MACS12 level was missing. The study of Vaz et al. was performed before the 
MACS levels were published. In the study of Crowner and Racette,16 only two children were included 
for the reliability part of the study and in the study of Vaz et al., 11 children. Also, other information 
about COSMIN design requirements, such as the time interval, was not described. Moreover, for exam-
ple, in the study of Vaz et al.4 Important information about test conditions and the independence of 
measurements was not described.
For the IGPS measurements in this study, all test–retest reliability ICC values and all inter-rater 
reliability ICC values showed excellent reliability. No previous study has reported clinometric prop-
erties of the E-link Evaluation system in children with USCP. Nevertheless, the results are in line with 
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those reported in another study involving healthy participants (adults, 18–25 years).17 Furthermore, the 
part of the E-link Evaluation system which was used for determining grip strength shows similarities 
with the Jamar dynamometer. The reliability of the Jamar dynamometer was reported in the study 
of Klingels et al., and both test–retest (ICC 0.96) and inter-rater (ICC 0.95) reliability were excellent. 
This study was rated moderate according to the COSMIN criteria [8]. In terms of appearance, size and 
function, both instruments are more or less the same. The differences between the Jamar and the 
E-link are that they have different manufacturers, and the Jamar has incremental steps of 0.45 kg (1 lb), 
whereas the E-link Evaluation system has incremental steps of 0.1 kg.
As the present study fulfils the COSMIN criteria for a study with good methodological quality, 
it can be concluded that almost all arm/hand strength measurements have excellent test–retest reli-
ability and excellent inter-rater reliability in the group of children with USCP, aged 7–12 years. Only the 
inter-rater reliability of the elbow flexion of the AH was classified as “good”, meaning there was more 
variability in the performance of this measurement. A possible explanation for this variability in the 
performance of this measurement could be the higher muscle strength values. With higher muscle 
strength values, it is more difficult for the therapist to check/control that there is no movement in the 
joint. Reviewing the above-mentioned results, it can be concluded that both methods can be used 
reliably for cross-sectional measurements, for example, as a screening instrument or to determine UE 
strength in children with USCP.
However, besides test–retest reliability and inter-rater reliability, the SEM and SDC-values are 
important components of reliability.9 SEM and SDC values for these measurement instruments have 
not been reported before. With the SEM and SDC values, the usability in patients in clinical practice can 
be determined, certainly when these instruments are used to determine changes over time in individ-
ual patients. In order to correctly interpret changes, for example, after a strength training program, one 
needs to know how much improvement is necessary to be sure that this improvement is not due to 
error. So, the change needs at least to be larger than the SDC. Unfortunately, so far, no clear informa-
tion is available on how much improvement a child with USCP can achieve after a strength-training 
program. However, in cases where the muscle strength at baseline of a child is already less than the 
SDC-value, it will be very unlikely that by any intervention one can achieve an improvement (i.e., more 
than double the strength) above the SDC threshold. So, the utility of both instruments for measuring 
changes in muscle strength can there- fore be a problem in children with USCP with low muscle 
strength (below the SDC-value). Therefore, currently it is not possible to draw firm conclusions about 
the usability of both measurement instruments to measure changes over time. Additional research 
on the effects of strengthening and other interventions of the upper extremities in children with USCP 
is recommended to draw firm conclusions about the usability of the instruments in clinical practice, 
especially in children with USCP with low muscle strength.
Limitations
Age, gender and MACS level were not ideally distributed, and therefore, some of these variables could 
have influenced the results. As this study population has an age range of 7–12 years, caution is advised 
when testing children of different age groups. The population size was too small to calculate separate 
ICC/SEM/ SDC values for each MACS level.12 Caution is advised when testing children with USCP with 
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MACS-level III, because of the small population of included children. Unfortunately, group size was 
also too small to determine the specific characteristics of children with a muscle strength below the 
SDC value. Another limitation of the study could be the high number of measurement therapists, 
as this could have resulted in higher measurement errors. However, the high number of therapists 
involved in the measurements resembles clinical practice.
Conclusions
The HDD and E-link system are usable measurement instruments in cross-sectional measurements of 
UE muscle strength in children with USCP. It is not clear if both instruments are usable for measuring 
changes in UE muscle strength within one person, especially if a child with USCP has low muscle 
strength. Therefore, caution in the interpretation of changes in UE muscle strength is necessary. More 
research on the effects of strengthening interventions of the upper extremities in children with USCP 
is recommended. Once the effects of strengthening interventions of the upper extremities in children 
with USCP have been examined, the usability of all instruments for longitudinal measurements will 
require reconsideration.
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Abstract
Background. For children with unilateral spastic cerebral palsy (USCP), 
reduced muscle strength can lead to activity limitations. However, none of 
the existing measures of upper extremity strength measure strength in the 
context of functional activities in which strength must be maintained for 
several seconds.
Objective. The objective of this study was to evaluate the psychometric 
properties of 2 newly developed functional hand and upper extremity mus-
cle-strength tests (Cup-Task and Box-Task) in children aged 7 to 12 years with 
USCP.
Design. A longitudinal study design was used.
Methods. A standardized protocol with detailed descriptions of all proce-
dures and measurements was used to determine test-retest reliability, inter-
rater reliability, and criterion validity.
Results. A total of 86 children (53 males, 33 females, mean age = 9.3 years) with 
USCP participated in this study, with a subset performing each measurement. 
Only the results of children who were able to perform the measurement were 
included for analysis. Excellent test-retest reliability (intraclass correlation coef-
ficients = 0.887–0.944; 95% confidence intervals = 0.713–0.969) and interrater 
reliability (intraclass correlation coefficients = 0.896–0.960; 95% confidence 
intervals = 0.813–0.980) were observed. The Cup-Task Affected-Hand and Box-
Task were moderately correlated with maximum isometric grip strength. The 
Cup-Task Nonaffected-Hand had a low correlation with maximum isometric 
grip strength.
Limitations. Age, sex, and manual ability were not normally distributed, 
which could have influenced the results.
Conclusions. For children with USCP who can perform the tasks, the Cup-
Task and BoxTask are reliable and valid instruments for measuring functional 
upper extremity muscle strength.
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Introduction
Impaired performance of upper extremity activities is reported in ~50% of children with unilateral 
spastic cerebral palsy (USCP), and these impairments affect the children’s independence and quality of 
life.1,2 Brændvik et al concluded that muscle strength strongly correlates with activity and that reduced 
strength can result in activity limitations.3 Upper extremity activities are assessed using a number of 
clinical tests and questionnaires. The National Institutes of Health Common Data Elements recom-
mends a variety of supplemental tests for assessing upper extremity motor function for children with 
cerebral palsy.4 These tests include the ABILHAND-kids,5 the Assisting
Hand Assessment,6 the Melbourne Assessment-v2,7 the Quality of Upper Extremity Skills Test,8 
and the Shriners Hospital Upper Extremity Evaluation.9 Recommended exploratory measures of dex-
terity include the Box and Blocks Test of Manual Dexterity,10 the Jebsen-Taylor Test of Hand Function,11 
the Nine-Hole Peg Test,12 and the Purdue Pegboard.13 All of these instruments measure function (active 
and passive range of motion, tone, segmental alignment of the extremity) or quantify the capacity 
(upper extremity use in a standardized, controlled environment), capability (upper extremity function 
in the daily environment), or performance (actual use of the upper extremity in the daily environ-
ment) of the upper extremity. However, none of these measures directly consider the role of strength 
in upper extremity activities.
For upper extremity strength measurements, the National Institutes of Health Common Data 
Elements recommends maximum voluntary isometric contraction testing using hand-held dyna-
mometers and a grip/pinch dynamometer, and manual muscle testing using the Medical Research 
Council Muscle Grading Scale14 to determine different grades of muscle strength. Within manual mus-
cle testing, grades 4 and 5 seem insufficiently sensitive to assess muscle strength or to detect small to 
moderate increases of strength.15
In most manual activities, not only is a certain amount of muscle strength required, but also 
the ability to maintain that strength for a short time (2–5 seconds), for example, during carrying/
moving a heavy box. Therefore, a certain level of coordination is also necessary to perform the tests 
adequately. Measuring muscle strength during a functional task in which it is expected that muscle 
strength plays a major role (ie, “functional strength” measurements) enables measurement not only 
of the strength of different simultaneously working muscles but also the task-specific generation of 
the strength.
For children with USCP, various functional muscle-strength tests for the lower extremity are 
available, including the “Lateral Step-up,” “Sit-to-Stand,” and the “Attain stand through half kneel, with-
out using arms” tests.16 For the upper extremities, the “functional strength measurement” test is feasi-
ble in children with CP.17 With this test, maximum explosive muscle strength and 30-second repetitive 
measurements are recorded. Unfortunately, the ability to maintain the functional strength in a sus-
tained contraction is not measured with the currently available muscle-strength tests. Thus, there are 
no functional upper extremity strength measures that quantify strength when sustained contractions 
are required. Therefore, we have developed 2 specific functional muscle-strength tests in the context 
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of unimanual and bimanual activity: the “Cup-Task” for determining maximal functional unimanual 
upper extremity strength, and the “Box-Task” for determining maximal functional bimanual upper 
extremity strength. Both tests measure a combination of functional grip and arm strength which must 
be sustained for 5 seconds. In a pilot study, both tests were found to be feasible in children with USCP.18
We used the COSMIN (COnsensus-based Standards for the Selection of health Measurement 
INstruments) checklist (www.cosmin.nl) as guidance for designing and reporting our study on the 
clinimetric properties of this new instrument. The COSMIN checklist is a consensus-based checklist 
that can be used for selecting a measurement instrument, peer reviewing a manuscript, and design-
ing or reporting a study on measurement properties.19 With the checklist, the methodological quality 
of a study can be classified as poor, moderate, good, or excellent.20
The objective of our study was to investigate test-retest and interrater reliability of the Cup-
Task and Box-Task for children aged 7 to 12 years with USCP. A secondary objective was to assess the 
criterion validity of the Cup-Task and Box-Task.
Methods
Study Design
A longitudinal study design was used. Ethics approval was granted by the Medical Ethical Board of 
the Maastricht University Medical Center and Maastricht University (METC azM/UM, trial number 
NL45430.068.1) in the Netherlands and at Teachers College, Columbia University, New York City, New 
York (USA). Data were collected in the Netherlands and United States from 2009 to 2016.
Participants
In the Netherlands, children were recruited from 4 rehabilitation centers and related special education 
schools, namely the Adelante Rehabilitation Centre in Valkenburg, Libra Rehabilitation and Audiology 
in Tilburg,
Revant Rehabilitation Centers in Breda and Goes, and Tolbrug Rehabilitation Centre in Den 
Bosch. In the United States, children were recruited while they were participating in ongoing intensive 
upper extremity studies at Teachers College, Columbia University.
To be included in this study, children were required to be diagnosed with USCP and aged 
between 7 and 12 years.
Furthermore, children had to be classified as GMFCS level I to II (Gross Motor Function Classifica-
tion System21), MACS-level I, II, or III (Manual Ability Classification System2), and be able to follow simple 
instructions. Children were excluded if within the past 6 months they had undergone surgery or received 
botulinum toxin-A treatment of the upper extremity. Children were also excluded for the test-retest 
reliability measurements if they were participating in an intensive upper extremity training program 
between the 2 measurements. The aim was to include more than 50 children per measurement.20
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Procedure
Measurements took place at the rehabilitation center where the children were being treated. A stan-
dardized protocol with detailed descriptions of all procedures and measurements was used. Prior to 
testing, the participants’ body weight and MACS and GMFCS levels were determined.
One set of strength measurements consisted of the Cup-Task, the Box-Task, and the E-LINK 
system. The sequence of the tasks was randomized. For the Cup-Task and E-LINK system, both the 
nonaffected hand (NAH) and the affected hand (AH) were measured.
To evaluate test-retest reliability, the set of strength measurements was conducted twice by the 
same assessor with a 2-week interval. This time interval was chosen because during normal develop-
ment (without intensive upper extremity training), no loss or gain in muscle strength was expected 
and memory of the first results would be limited. For the second session, test conditions were kept 
identical. For some children, the results of the second set of strength measurements were used for the 
premeasurements of intensive upper extremity studies, and the time span was sometimes extended 
to 4 weeks for these children due to scheduling difficulties.
To evaluate interrater reliability, 2 sets of strength measurements were conducted by 2 dif-
ferent assessors on the same day. There was at least 30 minutes of rest between each assessment. 
This amount of rest time was judged sufficient for the child to recover and limited the possibility 
for personal and environmental factors to change. If a child was measured for test-retest reliability 
and interrater reliability, the results of the first interrater reliability measurements were used for the 
test-retest reliability.
To evaluate criterion validity, a maximum isometric grip strength (IGS) measurement was per-
formed with the Biometrics E-LINK evaluation and exercise hand kit (Biometrics Ltd, Newport, Gwent, 
UK). The IGS measurement was performed 3 consecutive times, and the mean of the 3 measurements 
was calculated. Thus, variation in muscle strength, due to variations in grasping/handling of the mea-
surement instrument, was minimized. Between each measurement, the child had at least 30 seconds 
of rest to allow recovery.
Test scores were determined by the assessor and registered by the same assessor on a test form. 
In case of IGS measurements, test scores were also stored on the E-LINK evaluation system computer.
All measurements were performed by 8 different assessors, all (pediatric) physical therapists, 
who had no direct professional connection with the participants. Two of the assessors (K.D. and E.R.) 
are experienced pediatric research physical therapists and were involved during the entire project. 
The other 6 assessors were physical therapists who are studying for their advanced degree in pediatric 
physical therapy. They were involved in the study for 6 consecutive months. Each assessor received 4 
hours of training from K.D. or E.R. regarding the use of the standardized protocol in children with USCP. 
Before each measurement, each assessor had to read/practice the measurements protocol.
Measures
Both tasks were developed based on an expert’s opinion and the identification of the most frequently 
reported needs of the children with USCP in our Bimanual Intensive Movement Treatment. Goals 
involving lifting a box, tablet, or cup were most frequently reported by the children.
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Cup-Task: unimanual functional muscle-strength test. 
The goal of the Cup-Task was to test maximum unilateral functional muscle strength by determining 
the weight (in grams) the child could lift and hold for 5 seconds with 1 hand, using a measuring cup 
filled with adjustable weight. The equipment included an adjustable table, small weights, a water 
jug filled with 1000 cc water, and a measuring cup (322 g) with a maximum content of 1000 cc and 
a handle that could be held with the cylinder grip (see Fig. 1). The table was set at the height of the 
iliac crest of the child. The measuring cup was placed on the table. The NAH was tested prior to the 
AH. Between each attempt, 90 seconds of rest was provided. The number of attempts needed to 
determine the maximal weight could vary.
The child was instructed to lift the cup horizontally by flexing the elbow and fixating the wrist 
with the cup stable in the horizontal plane for 5 seconds without lowering it. The wrist was in the 
neutral position or in slight radial deviation. Ulnar deviation was only allowed when there was no 
other possible way to lift the cup and to keep it horizontal. After 5 seconds, the cup was replaced 
on the table.
Figure 1. Cup and box used for the Cup-Task and Box-Task.
cm = centimeter; g = gram; kg = kilograms.
Nonaffected hand. Each participant started the Cup-Task NAH with a starting weight of 500 g. 
After each successful attempt, a weight of 100 to 500 g was added until an attempt was unsuccess-
ful. The assessor was instructed to gradually build up to the maximum weight. If an attempt was 
unsuccessful, the weight was reduced in increments of 100 g until the child could perform the task 
as described.
Chapter 4
68
Affected hand. Because the abilities of the AH differ considerably between children with USCP, 
it is very likely that functional muscle strength of the AH also differs between children. Therefore, 
before the Cup-Task AH started, the starting weight was determined using water. First, the child was 
instructed to lift and hold the empty cup with a flexed elbow and fixated wrist and to keep it steady 
in the horizontal plane. Next, the assessor filled the cup with water, using a fluent movement, until 
the child could no longer hold the measuring cup horizontally. The amount of water was measured, 
and this amount was used as the starting weight for the first attempt. When, during the first attempt, 
the task was not performed as described, the weight was reduced by 100 cc of water for the second 
attempt. When the task was performed as described, in each attempt the weight was increased 
by increments of 100 cc until an attempt was no longer successful. Above 1000 cc the water was 
replaced by weights.
Box-Task: bimanual functional muscle-strength test. 
The goal of the Box-Task was to test maximum bilateral functional muscle strength by determining the 
weight (in kilograms) a child can lift and hold for 5 seconds with both hands using a box filled with 
weight bags. The equipment included an adjustable table and a plastic box (0.8 kg) with handles (Fig. 1).
The box was situated on a table with the height adjusted so that the top of the box was at 
the height of the child’s iliac crest. The child was instructed to lift and hold the box horizontally for 5 
seconds by flexing the elbows and fixating the wrists. After 5 seconds, the box was replaced on the 
table. The first attempt involved lifting the box without weight. If the weight of the empty box could 
be held according to the criteria, 0.5 to 2 kg (depending on how easy it was for the child to lift the 
box) of weight was supplemented. The assessor was instructed to gradually build up to the maximum 
weight. Between each attempt, 90 seconds of rest was provided. The number of attempts needed to 
determine the maximal weight could vary.
Isometric grip strength. 
Maximum IGS strength was measured with the Biometrics E-LINK evaluation and exercise hand kit, 
both in the AH and NAH. The E-LINK evaluation system is a calibrated, computerized system incor-
porating a modified (digitalized) grip dynamometer. The applied force was measured in 100-g incre-
ments. Children were seated in an upright position in a chair with back support and armrests. The 
initial posture was a neutral position (0°) of the wrist joint and 90° flexion of the elbow joint. The handle 
position of the E-LINK handgrip was adapted to the child’s hand size, according to E-LINK guidelines. 
The child was also asked whether the position of the handle felt comfortable. When there was doubt, 
other handle positions were attempted.
In children with USCP, a previous study showed excellent test-retest reliability (intraclass cor-
relation coefficient [ICC] values of 0.948 (95% confidence interval [CI] = 0.914–0.968) for the AH, and 
0.942 (95% CI = 0.904–0.964) for the NAH. Interrater reliability was excellent for the AH (ICC = 0.976; 95% 
CI = 0.959–0.986) and for the NAH (ICC = 0.960; 95% CI = 0.932–0.977).22
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Statistical Analysis
Before determining reliability and validity of the Cup-Task and Box-Task, the percentage of participants 
who could not perform each test was determined. The measurements of these participants were 
excluded for the reliability and validity analyses.
ICC, model 2-way random, type absolute agreement, with 95% CI were used to assess test-retest 
reliability and interrater reliability. An ICC greater than 0.80 reflects excellent reliability, whereas ICCs 
from 0.70 to 0.79 reflect good reliability.23
The standard error of measurement (SEM) agreement was calculated as the square root of the 
error variance (including the systematic error).24 The smallest detectable change (SDC) was computed 
as 1.96 multiplied by the square root of 2, multiplied by the SEM (SDC = 1.96 ×√2 × SEM).24
A simple and widely used method to interpret the SDC values is the Bland-Altman limits of 
agreement.25 An assumption of the limits of agreement is that the differences between 2 measure-
ments are normally distributed. When differences are not normally distributed, log transformation 
can be attempted.26 However, in log-transformed data, the antilog of the difference between 2 values 
on a log scale is a dimensionless ratio.25 For that reason, we only calculated limits of agreement when 
all differences were normally distributed (determined by the Shapiro-Wilk test).
To assess criterion validity, a Pearson correlation coefficient between the functional upper 
extremity strength measurements and the maximum IGS was calculated. For the Cup-Task AH and 
the Box-Task, a comparison with the IGS AH was made. For the Cup-Task NAH, a comparison with 
the IGS NAH was made. In all measurements, a significant moderate Pearson correlation coefficient27 
between 0.50 and 0.70 was hypothesized, because muscle strength seems to be the most important 
component of the functional strength measurement, but coordination and some endurance are also 
important components. The hypothesized values are also in line with previously reported validity 
values for functional strength measurement in children with CP.17 Values were considered statistically 
significant at P < .05.
Role of the Funding Source
This study was funded by the Forward for Children With Disabilities Foundation, Valkenburg, the 
Netherlands; the Revant Innovation Foundation, Breda, the Netherlands; and the Johanna Children’s 
Foundation, Arnhem, the Netherlands. The funders had no role in the design, data collection, analysis, 
interpretation, or reporting of this work, or the decision to submit the work for publication.
Results
A total of 86 children with USCP participated in this study. Because not every child performed every 
measurement (due to unavailability and/or measurement instrument), a different number of children 
was available for each test. For the statistical analyses of the reliability and validity values, only the 
children who could perform the specific measurement were included. See Figure 2 for a detailed 
description of the participant characteristics.
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The results of the reliability studies for all tasks at different time points are shown in Table 1 
(outcomes of the measurements) and Table 2 (reliability and validity).
Cup-Task AH
Test-retest reliability.
Of the 54 children tested, 9 children (16.9%) could not (adequately) perform 1 or more measurements 
with the empty cup. See Figure 2 for details.
Test-retest reliability was excellent (N = 45; ICC = 0.887; 95% CI = 0.713–0.948), with an SEM value 
of 284 g and an SDC value of 787 g.
Interrater reliability.
Of the 54 children, 11 (20.3%) could not (adequately) perform the measurement with the empty cup 
in one of the attempts. See Figure 2 for details.
Interrater reliability was excellent (N = 43; ICC = 0.960; 95% CI = 0.918–0.980), with an SEM value 
of 142 g and an SDC value of 393 g.
Criterion validity.
Of the 84 participants, 23 children (27.4%) could not perform the measurement with an empty cup and 
the IGS measurement. See Figure 2 for details. The Pearson correlation coefficient (N = 61) between the 
Cup-Task AH and IGS of the AH was moderate (r = 0.638; P ≤ .001).
Cup-Task NAH
Test-retest reliability
All 54 children were able to perform the measurements on repeated occasions (Fig. 2). Test-retest 
reliability was excellent (ICC = 0.944; 95% CI = 0.895–0.969), with an SEM value of 272 g and an SDC 
value of 755 g. As seen in the Bland-Altman plot (Fig. 3), there were several outliers, but these are 
included in the calculations.
Interrater reliability
All 54 children were able to perform the measurements during both tests (Fig. 2). Interrater reliability 
was excellent (ICC = 0.898; 95% CI = 0.825–0.941), with an SEM value of 421 g and an SDC value of 1166 g.
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Criterion validity
All 75 participants were able to perform both measurements. The Pearson correlation coefficient 
between the Cup-Task NAH and IGS NAH was low (r = 0.489; P ≤ .001).
Box-Task
Test-retest reliability
Sixty-five children performed both measurements, and 3 children (4.8%) were not able to perform 1 
or 2 measurements adequately. Test-retest reliability was excellent (N = 62; ICC = 0.934; 95% CI = 0.875–
0.963), with an SEM value of 1.38 kg and an SDC value of 3.82 kg.
Interrater reliability
All 54 children who participated in this part of the study were able adequately to perform the mea-
surements twice. Interrater reliability was excellent (ICC = 0.896; 95% CI = 0.813–0.941), with an SEM 
value of 1.82 kg and an SDC value of 5.05 kg.
Criterion validity
All 85 participants could lift the box and also perform the IGS adequately. For 1 child, an assessor deter-
mined that the empty box was the maximum weight capable of being lifted. The Pearson correlation 
coefficient between the Box-Task and maximum IGS AH was moderate (r = 0.555; P ≤ .001).
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Table 1. Outcomes
Task
Test-Retest  
Reliability
Interrater  
Reliability
Mean T0 
(SD)
Mean T1 
(SD)
Differ-
ence 
Between 
T0 and T1
Shap-
iro-Wilk 
Test (P 
value)
Mean T0 
(SD)
Mean T1 
(SD)
Differ-
ence 
Between 
T0 and T1
Shapiro-Wilk 
Test (P value)
Cup-Task AH 568 g 
(535 g)
787 g 
(687 g)
210 g 
(342 g)
≤ .001 602 g 
(475 g)
679 g 
(545 g)
77.3 g 
(187 g)
≤ .001
Cup-Task NAH 1500 g 
(836 g)
1637 g 
(823 g)
137 g 
(363 g)
.09 1622 g 
(1068 g)
1580 g 
(881 g)
42.7 g 
(599 g)
.01
Box-Task 5.79 kg 
(3.74 kg)
6.53 kg 
(3.99 kg)
0.74 kg 
(1.81 kg)
≤ .001 5.42 kg 
(4.03 kg)
6.26 kg 
(4.30 kg)
0.84 kg 
(2.46 kg)
≤ .001
AH = affected hand; Diff = difference; NAH = nonaffected hand.
Table 2. Psychometric Properties of the Measurement Instruments
Movement
Test-Retest  
Reliability
Interrater  
Reliability Criterion Validity
N ICC
95% 
CI SEM SDC N ICC
95% 
CI SEM SDC N
Pcc with 
IGS P value
Cup-Task AH 45 0.887 0.713–
0.948
284 g 787 g 43 0.960 0.918–
0.980
142 g 393 g 61 0.638 ≤ .001
Cup-Task NAH 54 0.944 0.895–
0.969
272 g 755 g 54 0.898 0.825–
0.941
421 g 1166 
g
75 0.489 ≤ .001
Box-Task 62 0.934 0.875–
0.963
1.38 
kg
3.82 
kg
54 0.896 0.813–
0.941
1.82 
kg
5.05 
kg
85 0.555 .001
AH = affected hand; CI = confidence interval; ICC = intraclass correlation coefficient; IGS = isometric grip strength; NAH = nonaffected hand; 
Pcc = Pearson correlation coefficient; SDC = smallest detectable change; SEM = standard error of measurement
Figure 3. Limits of agreement:
Cup-Task NAH test-retest reliability. NAH = nonaffected hand.
Chapter 4
74
Discussion
The purpose of this study was to evaluate the psychometric properties of 2 newly developed func-
tional hand and upper extremity muscle-strength tests in children aged 7 to 12 years with USCP.
Reliability
Not all the children were able to perform the Cup-Task AH sufficiently. Therefore, the number of 
included children for the reliability part of the study was lower than intended. For the Cup-Task NAH 
and Box-Task, the target population size was achieved.
All test-retest reliability ICC values and all interrater reliability ICC values for all measurement 
instruments showed excellent reliability. These results are in line with the previously performed pilot 
study.18 Because of the skewed distribution of the data of the Cup-Task AH and Box-Task, only the limits 
of agreement for the test-retest reliability of the Cup-Task NAH could be calculated. The Bland-Altman 
plot showed good agreement, as reflected by the narrow limits of agreement.
Because of the excellent test-retest reliability and excellent interrater reliability, all instruments 
can reliably be used for cross-sectional measurements, for example, to determine the muscle strength 
of the AH and NAH in children with USCP.
Beside test-retest reliability and interrater reliability, the SEM and SDC values are important 
components of reliability.24 SEM and SDC values for these measurement instruments have not been 
previously reported. With the SEM and SDC values, the usability in patients in clinical practice can be 
determined, certainly when these instruments are used to determine changes over time in individual 
patients. By using these values, it can be determined whether the changes in functional strength after 
a strength training program are larger than the changes that can occur due to variability between 2 
measurements. Unfortunately, no information is available on how much functional upper extremity 
strength improvement a child with USCP can achieve after such a training program. Therefore, it is not 
possible to draw clear conclusions about the usability of the measurement instruments to measure 
real and clinically important changes.
Criterion Validity
In more than 25% of the participants, the assessor judged that the child was not able to perform the 
Cup-Task AH. Therefore, this measurement instrument is not suitable for a substantial proportion of 
children with USCP. Subanalyses of the participants who could not perform the task showed a wide 
distribution of age, sex, and MACS level; they included 5 children with MACS level I, 14 children with 
MACS level II, and 4 children with MACS level III. Comparing these MACS levels with those of the 
children included in the validity study (MACS level I, n = 22; level II, n = 33; level III, n = 6; see Fig. 2), it 
might be concluded that this task is more difficult to perform for children with MACS level III. Within 
the MACS level III group, most children were unable to lift the cup horizontally with the AH because 
they could not grasp the handle of the cup. For the children who were able to perform the Cup-Task 
AH, the Pearson correlation coefficient met the expectations. Therefore, it can be concluded that the 
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Cup-Task AH is valid for the children who are able to perform the task. For the children who could not 
perform the Cup-Task AH, another measurement instrument is needed to measure functional hand 
and upper extremity muscle strength.
The Cup-Task NAH and Box-Task were feasible for all participants, irrespective of the MACS level. 
The Pearson correlation coefficient of the Box-Task also met the expectations. However, the Pearson 
correlation coefficient of the Cup-Task NAH (r = 0.489) was just below the expected range (0.50–0.70).
Because these functional strength instruments have not been studied previously with children 
with USCP, no direct comparison with other studies can be made. Of the 11 supplemental tests recom-
mended by the National Institutes of Health Common Data Elements for assessing upper extremity 
motor function in children with CP, only maximum voluntary isometric contraction testing and man-
ual muscle testing measure muscle strength, and none measure upper extremity functional strength.4 
Thus the current tests have the potential to expand the number of reliable and valid tests for this 
population, and fill an important gap in our understanding of strength in the context of function.
Strengths and Limitations
The strength of this study is its methodological quality. The COSMIN criteria were important for the 
design of this study, which resulted in scientifically valuable results.
Unfortunately, age, sex, and MACS level were not ideally distributed, which could have influ-
enced the results.
Because this study focused on the age range of 7 to 12 years, caution is advised when testing 
children in other age groups. The population size was too small to calculate separate ICC/SEM/SDC 
values for each MACS level. The small number of children included in this study with MACS level III 
means that caution is advised when testing such children. Moreover, the large number of assessors 
could be a limitation of the study because this could have resulted in more measurement errors. 
However, the large number of assessors more closely resembles clinical practice.
Conclusion
The Cup-Task and Box-Task are reliable and valid measurement instruments for measuring functional 
hand and upper extremity muscle strength in children with USCP who can perform such tasks. How-
ever, in most cases, for children with USCP and MACS level III the Cup-Task AH will not be suitable. 
To determine the usability of both instruments in children with USCP in longitudinal measurements, 
more research on the effects of increasing functional upper extremity strength in children with USCP 
is recommended.
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Abstract
Objective: The objective was to investigate whether muscle strength in the 
non-affected and affected upper extremity (UE) in children (7–12 years) with 
Unilateral Spastic Cerebral Palsy (USCP) differs from that in children with typ-
ical development (TD).
Methods: A cross-sectional study design was used. In children with USCP, iso-
metric arm strength (wrist flexion, wrist extension with flexed and extended 
fingers, elbow flexion/extension) was assessed in 72 children (mean [SD] age 
9.3 [1.9] years) and isometric grip/pinch strength was assessed in 86 children 
(mean [SD] age 9.3 [1.8] years). For children with TD, arm/grip/pinch strength 
was assessed in 120 children (mean [SD] age 9.5 [1.7] years). Arm strength 
was measured with the MicroFET2 hand-held dynamometer and grip/pinch 
strength with the Biometric E-Link evaluation system. The non-affected UE 
of children with USCP was compared with the preferred UE of children with 
TD, because both sides represent the preferred UE. The affected UE was com-
pared with the non-preferred UE of children with TD, as both sides represent 
the non-preferred UE.
Results: In all measurements except for grip strength of the preferred UE, 
children with USCP were weaker than children with TD.
Conclusions: In children with USCP, muscle strength weakness exists in both 
upper extremities.
Impact statement: When uni- or bimanual ability limitations are present in chil-
dren with unilateral cerebral palsy, investigation of the muscle strength of the 
non-affected UE should be part of the assessment.
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Introduction
Unilateral spastic cerebral palsy (USCP) is characterized by motor impairments lateralized to one body 
side, resulting in an “affected” body side and a “non-affected” body side.1–3 Several studies have shown 
that muscle strength of the affected upper extremity (UE) is considerably impaired compared to the 
non-affected UE and compared to the UE strength of children with typical development (TD).4–6 Mus-
cle strength weakness of the affected UE is one of the motor impairments affecting manual abilities.6,7
Several magnetic resonance imaging (MRI) studies in children with supposed USCP have 
shown bilateral brain lesions.8–11 Also, many clinicians perceive problems in the “non-affected“ body 
side, and often this described possible impairments of the “non-affected” body side or found reduced 
performance of the “non-affected” UE in children with cerebral palsy compared to children with TD.12–15
Whether muscle strength weakness in the more-affected UE is the cause of this reduced perfor-
mance is unclear, and one should keep in mind that these differences can also be attributed to prob-
lems with speed and/or coordination. So far, only two studies have investigated the muscle strength of 
the non-affected hand in children with USCP, with opposite conclusions. One study showed that grip 
strength of the non-affected hand of the children with USCP was, on average, 12% weaker compared 
to a group of children with TD.12 Another study found no significant differences between grip/pinch 
strength of the non-affected hand of children with USCP compared to norm values of children with 
TD.14 Both studies only studied grip/pinch strength and studies on the strength of the non-affected 
forearm and upper arm muscles are lacking. Hand strength is important for executing fine motor 
activities, but also the strength of upper and lower arm muscles is important during gross motor 
UE activities, such as lifting and carrying objects. It is therefore important to assess whether muscle 
weakness in the non-affected UE is present or not, as this might have consequences when selecting 
the proper assessment/treatment to map/improve UE function.
Research on this topic has been done among adults after unilateral stroke. Several studies have 
reported motor impairments in the non-affected UE in adults after unilateral stroke.16–23 Although 
these motor impairments are substantially less severe than in the affected UE, they can produce sig-
nificantly limiting (bilateral) functional impairments, including problems performing the activities of 
daily living.24–26
In more than 50 papers, most of which focused on activities involving the lower limb of adults 
with unilateral stroke, muscle strength appeared to be related to functional activity performance.27 
Such a relationship was also demonstrated for the upper limb28 and it has been proven that strength-
ening interventions do not only improve muscle strength but also activity after stroke.29
Although the cause for both USCP and stroke originates in the brain, the body functions 
in children with USCP have hardly developed at the time the brain injury/malformation occurs. 
Because children with USCP only use their non-affected UE spontaneously in daily activities,30,31 the 
non-affected UE is maximally stimulated during development. Adults who have had a stroke used 
both hands normally before the stroke occurred. Therefore, it cannot simply be concluded that the 
findings in adults with stroke also apply to children with cerebral palsy.
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The aim of this study was to investigate whether muscle strength in the “non-affected” UE in children 
with USCP differs from children with TD. As prior studies that assessed the strength of the affected side 
used small sample sizes and/or only studied hand strength and/or used a measurement instrument 
that shows wide grading values when applied in children with moderate to good muscle strength,4–6 
the muscle strength of the affected UE is also examined within this study.
Methods 
Study design
All data were obtained according to a cross-sectional study design. Data were collected in The 
Netherlands and the USA from 2009 to 2017.
The non-affected UE of children with USCP was compared with the preferred UE of children 
with TD, because both sides represent the preferred UE. The affected UE was compared with the 
non-preferred UE of children with TD, as both sides represent the non-preferred UE.
Participants
Permission was granted by the Medical Ethical Board of the Maastricht University Medical Center and 
Maastricht University (METC azM/UM; trial number NL45430.068.1) in The Netherlands and by Teachers 
College, Columbia University in New York City, USA.
For the children with USCP, muscle strength values were obtained from a study on the reliability 
of maximum isometric arm and grip/pinch strength measurements.32 Within this study population the 
sample sizes for arm and grip/pinch strength varied due to the availability of the children and/or mea-
surement instruments at the facilities. Children were recruited from four different Dutch rehabilitation 
centers and related schools for special education: Adelante Rehabilitation Center, Valkenburg; Libra 
Rehabilitation and Audiology, Tilburg; Revant Rehabilitation Centers, Breda and Goes; and Tolbrug 
Rehabilitation Center, Den Bosch. In the USA, the children with USCP were a convenience sample of 
children participating in an ongoing intensive UE training program at Teachers College, Columbia 
University. To be included, the child had to be diagnosed with USCP and aged between 7 and 12 
years. The child also had to be classified as Gross Motor Function Classification System (GMFCS)33 level 
I or II and Manual Ability Classification System (MACS)34 level I, II or III. All participants were capable 
of following simple instructions. A child was excluded when he/she had surgery or botulinum toxin 
A treatment in the UE in the past six months.
The children with TD were recruited in The Netherlands. Primary schools in different regions, 
both in cities and the countryside, were approached to participate in this research. After informed 
consent of the management of the school, children were selected at random and invited to partici-
pate in this study. After informed consent had been received from their parents (and from the children 
aged 12 years), the children were invited for the measurements.
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Procedure
The measurements took place in the child’s own environment: the rehabilitation center for the chil-
dren with USCP; and primary school for the children with TD.
A standardized protocol with detailed descriptions of all procedures and measurements was 
used. Prior to testing, body weight and height, MACS and GMFCS level (for the children with USCP) 
were determined. All children performed one set of strength measurements, consisting of isometric 
arm strength (IAS) with the hand-held dynamometer (HHD) and isometric grip/pinch strength (IGPS) 
with the E-Link evaluation system (see Measures for a description). The sequence of strength measure-
ments was randomized. Both upper extremities were measured successively, with the preferred UE 
being tested before the non-preferred UE.
The HHD and E-Link measurements were performed three consecutive times and the mean 
of the three measurements was calculated. In this way, variation in muscle strength due to varia-
tions in placing the measurement instrument near the described measurement spot was minimized. 
Between each measurement, the child had at least 30 seconds of rest, leaving sufficient time for the 
muscles to recover.
Test scores were read by the therapist and registered by the same therapist on a test form. For 
the E-Link evaluation system, test scores were also stored on the E-Link evaluation system computer.
All measurements were performed by ten different assessors having no direct professional rela-
tionship with the participants. Two of the assessors (K.D., E.R.) involved during the entire project were 
experienced pediatric research physical therapists. The other eight assessors involved in the study 
for 6 months were master’s students in pediatric physical therapy. Each assessor received 4 hours of 
training from K.D. or E.R. regarding use of the standardized protocol.
Measurements
The child was seated in an upright position on a chair with back support and armrests. The armrests 
of the chair were used to support the arms during testing. The initial posture was a neutral position 
(0°) of the wrist joint and 90° flexion of the elbow joint. For elbow extension, the initial posture was 
adjusted so that the lower arm could move and elbow extension was possible. If a child was unable to 
perform the test, the result of the measurement was not used in the analysis.
Isometric arm strength (IAS)
Maximum isometric muscle strength of the wrist extension with extended fingers, wrist extension 
with flexed fingers, wrist flexion and elbow flexion/extension were measured with the MicroFET2 HHD 
(Hoggan Scientific LLC, Salt Lake City, UT, USA). The HHD is an electronic device that fits in the palm 
of the hand of the assessor. A load cell (strain gauge technology) measures the isometric muscle 
strength applied to a transducer. The “make method”, in which the child applies force against a fixed 
HHD, was used.35 The applied force was measured in Newtons. Children were encouraged by the ther-
apist to produce maximum force. Reliability of the measurements for children with USCP is excellent.32
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Isometric grip/pinch strength (IGPS)
The IGPS was measured with the Biometric E-Link evaluation system (Biometrics Ltd, Gwent, UK), 
a calibrated, computerized system that incorporates a modified (digitized) grip dynamometer and 
a pinch meter. The applied force was measured in 0.1 kilograms. The handle position of the E-Link 
handgrip was adapted to the child’s hand size according to the E-Link guidelines for positioning. The 
child was also asked where the position of the handle felt the best. When there was uncertainty, other 
handle positions were tried. Children were encouraged by the therapist to produce maximum force. 
Reliability of the measurements in children with USCP is excellent.32
Statistical analysis
All statistical analyses were performed using R.
Participant Characteristics
Descriptive statistics including means, standard deviations, and confidence intervals were used to 
summarize participant characteristics and strength measurements by age and group (children with 
USCP or children with TD). Independent samples t-tests were used to compare baseline characteristics.
Isometric Arm Strength (HHD)
Exploratory analyses revealed positive correlations between measures of arm-strength in the five dif-
ferent positions (wrist extension with extended fingers, wrist extension with flexed fingers, wrist flex-
ion, elbow flexion, elbow extension). Rather than analyzing each outcome separately, and in order to 
avoid Type I errors, a multivariate analysis of variance (MANOVA) was performed on the five variables 
(as a matrix of dependent variables), with age, sex, group, and an age × group interaction as indepen-
dent variables. A separate MANOVA was performed for the preferred UE and the non-preferred UE.
Given that MANOVA does not permit specification of how the combination of dependent 
variables differ between groups, linear discriminant analysis (LDA) was performed as a follow-up. LDA 
is a dimensionality reduction technique that can be used to characterize two or more classes/catego-
ries. For these analyses, we used LDA to examine which variables best distinguished between the two 
groups (children with USCP and children with TD).
Isometric Grip/Pinch Strength (E-Link)
The analysis for grip and pinch strength involved 4 generalized linear models (GLM) that were fit using 
a Gaussian distribution with an identity link. The models were separately fit to evaluate the difference 
between groups for 1) grip strength of the preferred UE, 2) pinch strength of the preferred UE, 3) grip 
strength of the non-preferred UE, and 4) pinch strength of the non-preferred UE. Age, sex, and an 
age × group interaction were also included in the models to adjust for their potential impact, with 
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the associations between age and strength assumed to be linear. In our specific analysis, the group 
children with USCP was set as the reference group. Thus, the parameter estimate for group is the 
difference between the group of children with TD relative to the group of children with USCP, when 
adjusted for age, sex, and age × group interaction. Given the possibility of heteroscedasticity, robust 
standard errors were computed for the parameter estimates using generalized estimating equations 
with an independent correlation structure. P-values were computed using a Wald statistic.
Results
Participant characteristics for gender, age, height, weight, preferred/non-preferred side and MACS- 
levels (for children with USCP) are provided in Table 1.
All children were able to perform the measurements. For children with USCP, muscle strength 
values of 72 children for the IAS measurements and 86 children for the IGPS measurements were 
taken. For the children with TD, a total of 120 children were included in all measurements. There were 
no significant differences between the groups in age (USCP-IAS/TD: p = 0.53; USCP-IGPS/TD: p = 0.56), 
height (USCP-IAS/TD: p = 0.07; USCP-IGPS/TD: p = 0.06) or weight (USCP-IAS/TD: p = 0.93; USCP-IGPS/
TD: p = 0.88).
Table 1: Descriptives of the participants.
USCP Age-groups
Isometric Arm Strength measurements (HHD)
n = 72; 45♂, 27♀
Mean age 9 years 3 months. SD 1 year 9 months.
45 right side affected. 27 left side affected
MACS level; I: n = 23. II: n = 42. III: n = 7
Mean height = 139cm; SD 12.3cm
Mean weight = 37.2kg; SD 10.2kg
Age 7; n = 17 9♂, 8♀
Age 8; n = 12 5♂, 7♀
Age 9; n = 12 9♂, 3♀
Age 10; n = 8 5♂, 3♀
Age 11; n = 7 5♂, 2♀
Age 12; n = 16 12♂, 4♀
Isometric Grip and pinch strength measurements 
(e-link system)
n = 86. 53♂, 33♀
Mean age 9 years 3 months. SD 1 year 8 months.
51 right side affected. 35 left side affected
MACS level; I: n = 29. II: n = 47. III: n = 10
Mean height = 139cm; SD 12.2cm
Mean weight = 37.0kg; SD 10.1kg
Age 7; n = 19 10♂, 9♀
Age 8; n = 14 6♂, 8♀
Age 9; n = 17 11♂, 6♀
Age 10; n = 9 5♂, 4♀
Age 11; n = 11 9♂, 2♀
Age 12; n = 16 12♂, 4♀
TD Age-groups
All measurements
n = 120. 60♂, 60♀
Mean age 9 years 5 months. SD 1 year 7 months.
Preferred right side: n = 106; preferred left side 
n = 14
Mean height = 143cm; SD 12.6cm
Mean weight = 37.4kg; SD 11.6kg
Age 7; n = 20 10♂, 10♀
Age 8; n = 20 10♂, 10♀
Age 9; n = 20 10♂, 10♀
Age 10; n = 20 10♂, 10♀
Age 11; n = 20 10♂, 10♀
Age 12; n = 20 10♂, 10♀
♂ = male; ♀ = female; cm = centimeter; HHD = hand held dynamometer; kg = kilogram; MACS = Manual Ability Classification; n = population size; 
SD = standard deviation; TD = typically developing; USCP = Unilateral Spastic Cerebral Palsy.
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Isometric Arm Strength
Preferred UE
The means and differences in arm muscle strength are presented in Table 2. Table 3 provides the 
parameter estimates for the MANOVA. For the preferred UE, children with USCP were consistently 
weaker than children with TD. There was a significant interaction between age and group suggesting 
that differences between the two groups are not constant across the age groups for the combined 
dependent variables F(5, 183) = 2.49, p < .05, Pillai’s Trace = 0.063. Across the age groups, the difference 
in muscle strength of the elbow flexors and elbow extensors appear to change most between chil-
dren with USCP and children with TD. It is remarkable that at the age of 7, the group of children with 
USCP is stronger in elbow flexion and elbow extension than the group of children with TD. At the 
age of 12, the group of children with TD is stronger in these muscle groups compared to the group of 
children with USCP.
Discriminant analysis was used to determine if the five measurements of IAS differentiated 
between children with USCP and children with TD. Table 3 provides a summary of the linear discrim-
inant function coefficients associated with each measurement. Wrist extension, wrist extension with 
fingers flexed, and elbow extension provided the greatest contribution to group separation. Figure 
1 demonstrates the group separation using the values of the discriminant function for the group of 
children with USCP and group of children with TD. Despite differences between the two groups, there 
is some degree of overlap in the distributions.
Non-preferred UE
For the non-preferred UE, children with USCP were consistently weaker than children with TD. Table 
3 provides the parameter estimates for the MANOVA. There was a significant interaction between 
age and group suggesting that differences between the two groups are not constant across the age 
groups for the combined dependent variables F(5, 183) = 5.14, p < .001, Pillai’s Trace = 0.12. Across the age 
groups (young to old), the difference between the two groups changes the most for elbow flexion 
and elbow extension.
Table 3 provides a summary of the linear discriminant function coefficients associated with 
each measurement for the non-preferred UE. Wrist extension with fingers flexed and wrist flexion 
provided the greatest contribution to group separation. Figure 1 demonstrates the group separation 
using the values of the discriminant function for the group children with USCP and group children 
with TD. For most cases, there appears to be clear separation between the two groups.
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Table 3. Results from MANOVA and LDA of Isometric Arm Strength
Preferred Upper Extremity 
Variable Pillai's trace Approx F p*
USCP vs. TD (Group) 0.23 10.83  < 0.001
Age 0.30 15.53  < 0.001
Sex 0.02 0.75 0.586
Age × Group interaction 0.06 2.49  < 0.05
Non-preferred Upper Extremity 
Variable Pillai's trace Approx F p*
USCP vs. TD (Group) 0.68 78.92  < 0.001
Age 0.30 15.80  < 0.001
Sex 0.01 0.34 0.888
Age × Group interaction 0.12 5.14  < 0.001
Preferred Upper Extremity
Variable Discriminant Function Coefficients
Wrist Extension 0.031
Wrist Extension (fingers flexed) 0.033
Wrist Flexion 0.013
Elbow Flexion -0.008
Elbow Extension -0.030
Non-preferred Upper Extremity
Variable Discriminant Function Coefficients
Wrist Extension 0.019
Wrist Extension (fingers flexed) 0.029
Wrist Flexion 0.032
Elbow Flexion -0.009
Elbow Extension -0.012
TD = typically developing; USCP = Unilateral Spastic Cerebral Palsy;
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Figure 1. Group separation using the values of the discriminant function for the group of children with USCP and 
group of children with TD
Isometric Grip/Pinch Strength
The means and differences in grip and pinch strength are presented in Table 2. For three out of the 
4 measurements, analysis of grip/pinch strength resulted in statistically significant group differences. 
Table 4 summarizes the results for the fitted models. For pinch strength of the preferred UE, pinch 
strength of the non-preferred UE, and grip strength of the non-preferred UE, children with TD on aver-
age showed higher scores when controlling for age and sex. In addition, for grip strength of the 
non-preferred UE, there was a significant age by group interaction with children with TD showing 
greater gains in strength over time (Figure 2).
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Table 4. Results from GLM of Grip and Pinch Strength
 Estimate SE p*
Preferred Upper Extremity
Pinch Strength, kg
Intercept** 2.88 0.23  < 0.001
TD relative to USCP 0.76 0.29  < 0.01
One year increase in age 0.43 0.07  < 0.001
Female relative to Male -0.28 0.17 0.08
Age × Group interaction -0.09 0.10 0.41
Grip Strength, kg
Intercept** 9.74 0.85  < 0.001
TD relative to USCP 1.35 1.07 0.21
One year increase in age 1.76 0.27  < 0.001
Female relative to Male -0.68 0.64 0.29
Age × Group interaction 0.38 0.36 0.30
Non-preferred Upper Extremity
Pinch Strength, kg
Intercept** 1.23 0.20  < 0.001
TD relative to USCP 2.14 0.25  < 0.001
One year increase in age 0.19 0.06  < 0.01
Female relative to Male -0.12 0.15 0.44
Age × Group interaction 0.14 0.09 0.12
Grip Strength, kg
Intercept** 4.72 0.72  < 0.001
TD relative to USCP 6.79 0.90  < 0.001
One year increase in age 0.67 0.23  < 0.05
Female relative to Male -0.21 0.54 0.7
Age × Group interaction 1.24 0.31  < 0.001
*p-value calculated using Wald Stastic; **model was centered on age variable (intercept represents mean at age 7 years) 
with USCP group set as the reference group
kg = kilogram TD = typically developing; USCP = Unilateral Spastic Cerebral Palsy;
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Figure 2. Age by group interaction
Discussion
The aim of this study was to investigate whether the UE muscle strength between children with USCP 
and the children with TD differs for both the PUE and the non-preferred UE.
Muscle strength in the preferred UE
Overall, children with USCP were consistently weaker than children with TD in their preferred UE, 
except for grip strength. These findings are almost consistent with the findings in adults with stroke. 
In adults with stroke impairments in strength of the total UE were found.19,23
Muscle weakness of the preferred UE of children with USCP seems to go beyond impairments 
in the hand. It is striking that the muscle strength of the elbow flexion and extension in the younger 
age groups is higher in children with USCP than in children with TD. In the older age groups, this dif-
ference between groups is reversed. A possible explanation could be the intensive (bimanual) training 
in children with USCP at the younger age and more disuse of the preferred UE at the older age. More 
research to explain this result is needed.
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Rich et al.12 and Tomhave et al.14 assessed only differences in grip and pinch strength, so the 
results of these two strength measurements can be compared.
The results in our study regarding grip strength are comparable to the result of Tomhave et al.,14 
but different to that of Rich et al.12 In the study of Rich et al., older children (8–18y, mean 14,1y, sd 2.4y) 
were included.12 As figure 2 shows, the differences in grip strength becomes larger in the older age 
groups. This could explain why the differences in grip strength between the groups is probably not 
yet clear in our population.
Our findings regarding the difference in pinch strength contradict the study of Tomhave 
et al. (similar mean value compared to norm value).14 Although all studies use the average of three 
measurements to determine the muscle strength, some differences in methodology exist that may 
explain these discrepancies.
A different measurement instrument was used to measure grip strength: the digitized Biomet-
ric E-Link evaluation system (Biometrics Ltd, Gwent, UK) in our study versus a Jamar hydraulic hand 
dynamometer (Patterson Medical, Warrenville, IL, USA) in the other studies.12,14 The Biometric E-Link 
system has (digitized) incremental steps of 0.1 kg, whereas the Jamar hydraulic dynamometer has 
(visual) incremental steps of 2 kg/5 pounds. Therefore, small differences in muscle strength are more 
likely to be picked up using our E-Link system.
In our study and in the study of Rich et al.36 children with TD were used as controls, but Tomhave 
et al.14 compared the hand strength of children with USCP with previously published norms. These 
norms are based on 199 Brazilian children recruited within the same area and divided into ten age/
gender groups.37 About 37% of the American children were overweight or obese, whereas in Brazil this 
percentage is about 16–20%.38,39 Within The Netherlands this percentage is about 12%.40 As increasing 
weight status is associated with improved grip strength, 38 it is unclear whether the norm population 
sufficiently resembled the total population of children within the USA and The Netherlands.
Regarding our results, in most measurements the group of children with USCP showed a larger 
range of muscle strength compared to children with TD. These results cannot be compared to the 
other studies because this information is not available. With this larger range in muscle strength it is 
expected that specific characteristics related to children with USCP, such as MACS level and/or loca-
tion of the lesion, may have an impact on muscle weakness. However, due to the small subgroups (e.g. 
there are only 7–9 children with MACS level III), a comparison of muscle strength values for different 
MACS levels was not possible between children with TD and children with USCP.
Because there was no information on the overall activity and participation levels of the children 
with USCP, there is a chance that reduced overall activity and participation levels might have affected 
the hand function of the non-affected UE.
Unfortunately, MRIs or neurophysiological data for the children with USCP were not available, 
so we could not examine whether the muscle weakness in children with USCP is related to a specific 
brain damage location. In addition, it is not known how much of the deficit might be due to bilateral 
involvement of the brain.
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Muscle strength in the non-preferred upper extremity
In the non-preferred UE, for all measures the children with USCP produced statistically significantly 
lower muscle strength values compared to children with TD. These differences in muscle strength 
are in accord with other studies.4,5 Our study confirms the hypothesis that children with USCP can 
generate less muscle strength with the non-preferred side compared to children with TD. However, 
it is remarkable that the percentage difference in muscle strength is less in the proximal UE muscle 
groups compared to the distal UE muscle groups. A possible explanation is that the severity of hand 
function is closely related to the integrity and organization of direct corticospinal projections to the 
hand muscles and that these largely control distal movement/force.41 A second explanation might be 
that because most children with USCP only use the non-preferred UE to support the preferred UE, 
the proximal muscle groups may be used more compared to the distal (fine motor) muscle groups.
Limitations
We used a cross-sectional study design to compare differences in muscle strength between both 
groups. However, it should be noted that we did not study changes in muscle strength within each 
individual child. To do so a longitudinal study design is more appropriate, but such studies are logisti-
cally challenging to execute.
Because the age of our study population ranges from 7 to 12 years, these results cannot be 
extrapolated to other age groups.
The children with USCP are American and Dutch whereas the children with TD were exclusively 
Dutch children. Important patient characteristics, such as weight, height and age, did not differ signifi-
cantly between the two groups, therefore the possible influence of country of residence is likely to be 
minimal. However, because most participants were Dutch, it is unknown if the differences in muscle 
strength are generalizable to populations with a lower or higher percentage of overweight or obese 
children.
We tried to have all therapists testing both the children with USCP and children with TD, but 
unfortunately this was not always possible for practical reasons. Therefore, personal measurement 
errors could have influenced the results. However, the measurement therapists also participated 
in a reliability study and showing excellent reliability,32 indicating that they were likely sufficiently 
trained and consistent.
Although we already included more participants than most other studies on this topic, more 
participants are needed to be able to better differentiate which variables differs most between groups. 
Therefore, the results must be interpreted with some caution. A more global collaboration is needed 
to produce studies with a larger sample size.
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Conclusion
In children with USCP, muscle weakness in both upper extremities occurs. When uni- or bimanual 
ability limitations are present, investigation of muscle strength in the non-affected UE should be 
part of the assessment. Future research should focus on whether particular characteristics related to 
children with USCP can explain these differences in muscle strength and whether and where muscle 
weakness is present in the UE in adolescents with USCP.
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Chapter 7
General Discussion
Muscle weakness of the affected upper extremity (UE) is one of the main characteristics of a child 
with unilateral spastic cerebral palsy (USCP).1–3 This muscle weakness appears to be one of the most 
important causes of impairment in performance of UE activities.4–6 As a result, the primary goal of 
current therapy programmes is muscle strength training of the affected UE to facilitate performance 
during the numerous daily (uni- and bimanual) tasks.7–9
Measuring muscle strength is a common activity in daily practice for most clinicians working 
with children with USCP in order to determine whether muscle strength weakness is present (discrim-
inative) or whether muscle strength training has been effective (evaluative).
To be able to measure changes in muscle strength, one needs to know the degree to which 
variations in the measurement results between repeated measurements occur. This so-called mea-
surement error can arise from several sources: the measurement instrument itself, the examiner(s) 
performing the measurement, the patient undergoing the measurement and the circumstances 
under which the measurement is performed.10
Four out of five studies presented in this thesis focus on the clinimetric properties of various UE 
strength measuring instruments for children with USCP and on the interpretation of their outcomes, 
with the intention of clarifying how useful these measurement instruments actually are in clinical 
practice. The fifth study focuses on the muscle strength of the non-affected UE in children with USCP 
because it is not clear whether muscle weakness is a unilateral problem or whether the non-affected 
UE is also affected.
Aim
The primary aim of our research was to determine the clinimetric properties of four measurement 
instruments used in clinical practice to measure UE muscle strength in children with USCP. In addition, 
the aim was to appraise their overall usability for discriminative and evaluative purposes in children 
with USCP. The final aim of our research was to determine whether muscle strength problems are also 
present in the ‘non-affected UE’ of children with USCP.
Discussion outline
The outline of this thesis is divided into three main parts. First, the main findings will be discussed 
and contrasted to other findings reported in the international literature. Second, the ‘lessons learned’ 
about the methods used and the designs of our studies will be summarized and discussed. Third, 
there will be discussion on the current method of calculating the smallest detectable change (SDC) 
and whether this is suitable for muscle strength measurement instruments used in a (heterogeneous) 
rehabilitation population, as Chapters 3, 4 and 6 all show that the measurement instruments studied 
have a large SDC.
The discussion ends with two paragraphs on clinical implications and future research.
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1. Interpretation of the outcomes of the studies
The overall conclusion from our systematic review (Chapter 2) was that research on UE strength mea-
surements in children with CP needs to be improved, both in the number of subjects included and 
scientific quality. For example, we found that UE measurements with the hand-held dynamometer 
(HHD) were evaluated in two studies with a total of only 13 participants. In comparison, a systematic 
review from 2016 on the clinimetric properties of the HHD, used for measuring lower extremity muscle 
strength in children with CP, revealed seven studies with a total of 127 participants.11 In contrast to the 
studies reported in our review, the primary aim of all studies in the review on the use of the HHD in the 
lower extremities was to determine reliability and validity.
After our systematic review, one other systematic review has been published in which UE 
muscle strength measurement instruments were researched in children with dyskinetic CP.12 In this 
review only one paper was included in which a UE muscle strength measurement instrument was 
described (Biodex). However, the included paper did not report on clinimetric properties.13 As far as we 
know, no other papers have been published in which the clinimetric properties of UE measurement 
instruments for children with USCP are described. Therefore, the conclusion of our systematic review, 
that only a few measurement instruments used for discriminative purposes have been researched (in 
studies of low methodological quality), still appears to be valid.
In Chapter 3, the reliability of the HDD and the Biometrics E-link system are described. Review-
ing the literature up to May 2020, no other studies on the clinimetric properties of UE muscle strength 
measurement instruments for children with USCP have been published, making the HHD and E-link 
still the best researched measurement instruments for UE muscle strength in children with USCP.
Regarding the HHD and E-link, multiple measurement protocols are available. Although our 
protocol was developed by experts in paediatric rehabilitation, it would be useful to compare the 
results of our protocol with the results of other protocols. In this way, it is possible to determine which 
method, initial position of child and examiner and handling of the measurement instrument are most 
reliable. To our knowledge, our protocol is the only one that has been researched for its clinimetric 
properties in children with USCP, therefore we recommend our protocol for use in research and clin-
ical practice.
In most manual activities of daily life (e.g. carrying or moving a heavy box) it is relevant not only 
to measure the muscle strength but also the ability to maintain and regulate that strength during the 
performance of a task. This ability is called functional strength and it needs to be measured during the 
performance of a specific task. Two types of functional muscle strength tests have been developed: 
the ‘Cup task’ for determining maximal functional unimanual UE strength and the ‘Box task’ for deter-
mining maximal functional bimanual UE strength. In both tests, a combination of functional grip and 
arm strength is measured by lifting the box or cup, which must be sustained for 5 s.
At the start of this PhD trajectory, besides the Cup and Box tasks (Chapter 4), no other UE 
measurement instruments or other types of UE functional strength measurement instruments were 
available. Since then, only two other UE functional muscle strength measurement instruments have 
been researched in children with USCP: ‘functional strength measurement’ (FSM)14 and ‘task-oriented 
arm–hand capacity’ (TAAC) instrument.15
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The FSM consists of eight items, of which four measure UE muscle strength: one measures 
anaerobic muscle endurance (lifting a box) and three measure muscle power (overarm throwing, 
underarm throwing, chest pass). In the anaerobic muscle endurance item (lifting a box), the number 
of repetitions in a 30-s time frame is assessed; in the muscle power items, the distance a sandbag is 
thrown is measured in centimetres. One study concluded that the FSM is feasible, reliable and valid 
to use in children with CP.14 However, in contrast to the Cup and Box tasks, the UE items of the FSM 
are not specifically tailored to relevant therapy goals for children with USCP. For example, a goal for 
children with USCP related to lifting a box/object is mostly related to lifting (and holding) a heavy box/
object instead of lifting it several times. The muscle power items of the FSM contain throwing items, 
which are less related to daily living activities.
The TAAC instrument is a computerized version of our Cup and Box tasks, where, by means of 
a sensor, the force is registered and shown on a display. The TAAC measures the peak force while the 
child lifts a cup or box and is holding it for 5 s. Among the activities of daily life, the lifting of objects 
is a relevant task and common therapy goal in children with CP (e.g. lifting a school bag). The TAAC 
showed good test–retest reliability for the (bimanual) Box tasks and for the Cup task for the non-affected 
hand for children (6–18 years) with USCP.15 The results of the Cup task for the affected hand showed 
moderate test–retest reliability. An advantage of this digitalized version is that it can measure the force 
more precisely, as the minimum added weight, after the baseline weight was determined, was 100 g 
for the Cup task and 500 g for the Box task. Also, the chance of measurement error caused by a mistake 
in reading the computer display is lower than that of miscalculating the total amount of added weights 
by the tester. However, the costs of the TAAC are much higher compared to the Cup and Box tasks, 
therefore the TAAC is more applicable for research and the Cup and Box tasks for clinical practice.
As indicated above, it was not clear whether the muscle strength of the non-affected UE is 
affected. Alongside the expected weakness of the affected UE, we have hypothesized that the 
non-affected UE is also weaker compared to the norms of strength of the dominant hand of typically 
developing (TD) children. Several studies did report reduced performance in hand function of the 
non-affected UE compared to TD children.16–19 However, it was not known whether this reduced per-
formance is due to underlying muscle strength problems.
Only two studies have investigated the muscle strength of the non-affected hand in children 
with USCP, with opposite conclusions, therefore we compared the muscle strength of both hands to 
that in TD peers (Chapter 5).
Regarding the affected UE, our results support the studies that examined reduced muscle 
strength in the affected UE. 2,3,5 This muscle weakness of the affected UE appears to be one of the most 
important causes for the impairment in performance of UE activities.4–6,25 Several proven effective 
therapy programmes focus on training the affected UE to facilitate its use in performing a multitude 
of daily (unimanual and bimanual) tasks: 7–9,20–24 programmes such as constraint-induced movement 
therapy (CIMT), bimanual intensive movement therapy (BIMT) and a combination of both (hybrid 
CIMT). All these interventions aim to improve the function and performance of the affected UE in uni-
manual (CIMT) or bimanual (BIMT and hybrid CIMT) activities.
With regard to the non-affected UE, the results of our study support the findings that muscle 
weakness in children with USCP is present also in the non-affected UE.
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In addition to the fact that several magnetic resonance imaging (MRI) studies in children with 
supposed USCP have shown bilateral brain lesions25–28 and that several studies reported reduced 
performance of the non-affected UE in children with USCP,16–19 it is advisable not to speak of a purely 
unilateral disorder and to use the seemingly more appropriate term ‘less-affected UE’.
The factor that causes muscle weakness of the less-affected arm/hand has not been researched 
yet but because of the often-present bilateral brain lesions it is most likely that the muscle weak-
ness originates from reduced motor control. Furthermore, as children with USCP already use their 
less-affected UE more spontaneously in daily activities, muscle weakness as a result of disuse seems 
less likely.29,30
Whether the muscle weakness in the ‘less-affected’ UE leads to reduced performance has 
also not been researched. To perform UE activities, the strength of the affected hand in children 
with USCP and also in adults after unilateral stroke is an important component. 4–6,31,32 For example, 
in these populations it has been proved that strengthening interventions of the affected UE not only 
improve muscle strength but also the performance of activities.33,34 Thus, it could be hypothesized 
that in children with USCP muscle weakness of the less-affected UE results in reduced performance, 
in which case bimanual activity training seems to be more valid than just providing unimanual 
training of the affected UE.
Based on the results of the reliability studies, we wrote a critical perspective paper (Chapter 6) 
on the usability of the measurement instruments for discriminative and evaluative purposes. In this 
paper it is concluded that for the majority of children with USCP there is a high probability ( > 5%, 
p > 0.05) that the change in muscle strength is due to a measurement error. As an aside, it should 
be mentioned that it is not yet known how much gain in muscle strength can be achieved through 
muscle strength training if the right training stimulus is given.
In addition to the perspective paper, it is interesting to get an impression of the probability that 
the change in muscle strength is due to measurement error. To do so, the formula by which the SDC 
values are calculated (SDC = 1.96 × √2 × SEM, where SEM is the standard error of the mean) can be 
adapted. Within this formula, ‘1.96’ represents the Z score, which relates to a p value of 0.05 (a 5% proba-
bility that the change is due to measurement error). With this knowledge, the formula can be adapted 
to SDC = Z × √2 × SEM. By replacing the SDC value for the minimum important change (MIC) value, it 
is possible to calculate a new Z score: MIC = Z × √2 × SEM. With the new Z score, the corresponding p 
value can be determined and the probability of a measurement error calculated.
When we use the SEMs displayed in Chapter 3 within the formula, the outcome shows that 
when a change equal to or higher than the MIC (15% gain in muscle strength for the affected UE and 
20% for the less-affected UE) was measured, children with a muscle strength value at or below the 
2nd quartile have at least an 18–74% chance that the change score is due to measurement error. This 
level of probability is much higher than the current standards and therefore, purely based on these 
results, the recommendation for clinicians would be that in evaluation studies one has to be aware 
that for the majority of children with USCP there is a high probability that the change score is caused 
by measurement error. In children with low muscle strength values, the probability that the measured 
(clinicallchange is due to measurement error can be up to 95%. These results indicate that the HHD 
and E-link instruments are not usable for measuring changes in muscle strength in individuals. As 
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this phenomenon occurs in the HHD and E-link but also in the Cup and Box tasks, one may wonder 
whether this is typical for these measurement instruments. We will further elaborate on this question 
later in the discussion, after this next section.
2. Lessons learned about the methods and designs used in our studies
In our systematic review on measurement instruments to determine UE muscle strength in children 
with USCP in clinical practice (Chapter 2), we used the COSMIN checklist to assess the methodological 
quality of the studies.
For methodological quality there are various types of checklists. Some can be used to check 
for the presence of items reflecting methodological quality, for example the STROBE (STrengthening 
the Reporting of OBservational studies in Epidemiology) checklist.35 Others can be used to score the 
methodological quality of a study, for example the Cochrane Collaboration’s tool for assessing risk 
of bias in randomized trials36 and the Physiotherapy Evidence Database quality scale for randomized 
controlled trials (PEDro).37
Regarding assessment of the methodological quality of clinimetric properties, several standards 
and criteria have been proposed, as in the study of Lohr et al.38 and the quality criteria proposed 
by Audigé et al.39 However, these standards and criteria have not been transformed into applicable 
user-friendly checklists. Worldwide, there are only a few checklists by which the methodological quality 
of a clinimetric property study can be determined: examples are the Guidelines for Reporting Reliabil-
ity and Agreement Studies (GRRAS) and the Quality Appraisal of Reliability Studies (QAREL) checklists.40 
However, only the COSMIN checklist includes all clinical properties and is consensus based.
According to the original COSMIN checklist (2011),41 a study must include at least 50 participants 
to allow a good methodological quality score for population size. This is a very strict criterion that is 
not easy to achieve in a clinical study like ours. In 2018, the COSMIN group published a new checklist, 
the COSMIN Risk of Bias checklist,42 replacing the original COSMIN checklist.43 In this checklist it is rec-
ommended to take the aggregated sample size of the available studies into account when assessing 
the overall quality of evidence for a measurement property in a systematic review.44 A total of 50–99 
participants is needed to allocate the label of adequate quality and at least 100 participants for a very 
good methodological quality score.44 But even if we pooled the sample sizes of all included studies 
in our review, no measurement instrument would receive a higher methodological quality score. If 
we totally omitted the quality criterion of population size, some measurement instruments would 
be given a slightly better methodological quality score. However, the primary goal of most studies 
was not to determine the clinimetric properties, therefore these studies did not report on several 
other important criteria and the conclusion that there are only limited studies of poor methodological 
quality still holds.
The original COSMIN and the later COSMIN Risk of Bias checklists were developed for assessing 
the quality of studies on the measurement properties of patient reported outcome measures (PROMs). 
Because clinician reported outcome measures (ClinROMs) and performance-based outcome measures 
(PerBOMs) are typically more complex, requiring strict protocols, specific equipment and the involve-
ment of personnel, the COSMIN group is currently developing a new version of the checklist that can 
hopefully soon can be used on ClinROM and PerBOM studies. To reach consensus about the content 
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of this new checklist, the COSMIN group performed an international Delphi study among experts from 
various biomedical fields. A PerBOM checklist would have been more appropriate in our case. What 
influence the use of such a checklist would have had on the results presented in this thesis is hard to 
predict, as the checklist is still in the developmental stage. However, with the experience gained in our 
studies, we will now report our ideas on which items of the current COSMIN Risk of Bias checklist are 
useful in the new PerBOM checklist (related to reliability) and which new items are needed.
The current COSMIN Risk of Bias checklist contains four items on the statistical method: one 
item related to the patient (stable in the interim period), two items on the design (time interval appro-
priate, test conditions similar for the measurement) and one item named ‘other important flaws’. These 
four items are also appropriate to use in the ClinROM and PerBOM checklists.
The main difference between a PROM and a ClinROM/PerBOM is the difference in obtaining the 
results, namely by the patient (PROM) versus the examiner/test (ClinROM/PerBOM). There is no item 
on how the results were obtained, which is a particular feature of PerBOMs. Therefore, we recommend 
adding an item about the examiner. One well-trained examiner may not properly reflect how the 
results of the measuring instrument are commonly obtained in clinical practice. Another difference 
between a PROM and a ClinROM/PerBOM is that some ClinROMs/PerBOMs have strict protocols 
in which the instruction of the patient is precisely described. When these protocols are not followed 
by the examiner, there is a higher chance that larger measurement errors occur. Related to measure-
ment errors caused by deviations of the protocol/test instructions, the item ‘Were the test conditions 
similar for the measurements? e.g. type of administration, environment, instructions’ partly covers this 
topic. However, some measurements also require specific protocols in the use of the measurement 
instrument by the examiner. In such cases, an additional question, on whether the existing specific 
protocol of the measurement instrument has been properly used, should be taken into account.
In Chapters 3 and 4, the clinimetric properties of the HHD, E-link and Cup and Box tasks were 
described. To determine overall usability it is also necessary to look at the other clinimetric properties 
(validity and responsiveness for the HHD and E-link; responsiveness for the Cup and Box tasks).
The validity of the HHD has never been researched in the upper and lower extremities of 
children with USCP. Studies have involved other populations and often an isokinetic dynamometer 
(like the Biodex system) as the gold standard.45–47 However, during isokinetic muscle strength testing 
the patient needs to be able to cooperate with the examiner and to perform a maximal concentric 
contraction of one muscle group. For many children with CP this is a very difficult task to perform due 
to co-contraction of antagonists or agonists and/or cognitive limitations.48,49 Because of these specific 
characteristics of children with CP, we regard the isokinetic dynamometer not to be an appropriate 
comparator to serve as the gold standard. Therefore, research into the criterion validity of the HHD 
in children with CP using the isokinetic dynamometer for comparison is not appropriate. As the tester 
tries specifically to measure muscle strength on the function level of the ICF-CY (International Classifi-
cation of Functioning, Disability and Health – Children and Youth Version) with the HHD, research into 
the construct validity is more appropriate.
Regarding the validity of the E-link, the study by Allen et al. indicates that both the Jamar and 
Biometrics dynamometers measure the same construct of grip strength and that the E-link is a valid 
tool for measuring maximum voluntary grip strength in healthy university students (aged 18–25 
years).50 Unfortunately, no studies are published on the validity of the E-link in children with USCP, 
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therefore it is not certain that the Jamar can be used to check the validity of the E-link in children with 
CP, as these children have specific characteristics, such as cognitive limitations, that could influence 
the validity. Further research on this topic is needed to gain more clarity.
No research has been done on the responsiveness of the HHD, E-link and Cup and Box tasks for 
UE measurements in children with USCP. Given the high measurement error, we have doubts about 
the responsiveness. Further research is therefore needed before firm conclusions can be drawn about 
the usability of these instruments for evaluative purposes.
Chapter 5 focused on the differences in muscle strength between children with USCP and 
TD peers. When examining differences between populations, it is important that both groups are 
representative samples of their population. The TD peers were recruited from different parts of the 
Netherlands to obtain a representative sample. Regarding the children with USCP, only those who 
have had therapy at a rehabilitation centre were included. However, it cannot be determined whether 
this had a positive or negative impact on the results. Children with USCP who have (multiple) prob-
lems in activities visit a rehabilitation centre, therefore the children could have already had a muscle 
strength training programme and it is unknown whether this has influenced our results.
In the comparison of muscle strength between the children with USCP and TD peers, we used 
the outcome of the HHD, which depends on the distance between the HHD placement and the joint. 
To avoid differences in HHD outcome due to differences in arm length, one should calculate the 
torque (torque = lever-arm ´ force). Because we did not have information on the arm length of the 
children, we were not able to calculate this torque. In our study, the length, weight and age did not 
differ at group level, therefore standardization of the HHD outcome by calculating the torque would 
not have led to an altered conclusion. Nevertheless, when evaluating muscle strength over a longer 
period (years), it is advisable to include the lever-arm in measurements because it is likely that the 
lever-arm of the child increases due to natural growth of the child between both measurements. The 
same applies when muscle strength norm values are developed.
In Chapter 6 we discussed the usability of the measurement instruments from a critical perspec-
tive, where the most important weaknesses/flaws of the study design and measurement instruments 
used can be found.
3. Determining the smallest detectable change
The current method to determine the SDC uses measures of multiple participants and results in an 
absolute value for the total group. This method is recommended by the members/experts of the 
COSMIN group and is well researched within the focus area (PROMs) of the COSMIN.
A measurement error can be caused by four sources: the measurement instrument itself, the 
examiner(s) performing the measurement, the patient undergoing the measurement and the cir-
cumstances under which the measurement is performed.10 With the design of our studies, the use of 
a standardized protocol and training of skilled therapists, we tried to minimize the influence of these 
sources on the measurement error. Despite all these points of attention, relatively high SDC values 
were found in all the measuring instruments that we have researched. The question arises whether 
such high values are specific for these measurement instruments or related to the population (USCP).
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Therefore, we have examined the SDC values for the HHD in the lower extremities in children 
with USCP (the E-link measures grip/pinch strength) and for the HHD and E-link in other populations. 
As we developed the Cup and Box tasks recently, no other information about these measurement 
instruments could be found.
To gain more insight into the size of the SDC value, we converted absolute to relative SDC values (in 
%) by dividing the SDC-value by the average group value.
 — SDC values for the HHD in the lower extremities in children with CP:
Willemse et al. reported high relative SDC values in lower extremity strength measurements 
( > 20.6% for knee flexors and > 34.8% for ankle plantar flexors) in children with CP using the 
HHD.51 In this study, it was concluded that because previous strength training studies had 
reported lower extremity muscle strength increases of 11–74%, the HHD often will be insuffi-
ciently sensitive to detect individual strength gains.51
Van Vulpen et al. reported a 40–128% SDC value for the standing heel-rise test in children aged 
3–5 years and a 23–48% value in children aged 6–10 years for both the affected and less affected 
extremity.52 However, they concluded that they found acceptable SDC values for the isometric 
hip abductors (11%), knee extensor (9%) and calf (23% for M. gastrocnemius and 30% for M. 
soleus) muscle strength tests for both the affected and less affected extremity. In that study, 
all the measurements were performed by the same experienced/well-trained examiner. These 
results were achieved by taking the mean values of two or three test occasions (separate days) 
and repetitions. By using fewer repetitions and moments, the SDC values increased up to 57%.
Summarizing, high SDC values are found also in the lower extremities of children with USCP.
 — SDC values for the HHD and E-link in other populations:
For hand strength in TD children aged 4–12 years (performed with a Lode dynamometer, which 
is similar to the Jamar dynamometer), an SDC value of 23.2–27.0% of the mean maximum vol-
untary contraction was found.53
Also, high SDC values were found in healthy adults (20–30%),54 in adults with shoulder pain and 
functional loss (15% and 28%),55 in elderly with diabetes/chronic condition (28%, elbow flexion)56 
and in women with systemic lupus erythematosus (21%, grip; 21%, shoulder abduction; 18%, 
shoulder flexion).57
Summarizing, the HDD and E-link also have high relative SDC values in other populations.
Because high SDC values are found in both the lower extremities of children with CP and in other 
populations, we also examined the SDC values for other instruments that measure the same construct 
(muscle strength or endurance). 
 — The ‘functional strength measurement’ (FSM) in children with USCP also reveals high SDC val-
ues. The SDC values for the majority of the individual’s items were larger than the median. For 
the total score, the SDC value for the younger population (4–6 years) is just below the median 
(2.33 vs. 3.0) but for the older group (7–10 years) is more than half the median (2.8 vs. 5).
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For the muscle power sprint test, on comparing the SDC values and means a relative SDC value 
of 25–40% (mean power/peak power) was found.58
Two studies were published in which the SDC value of the Wingate anaerobic test in children 
with CP was reported. In one study, the SDC value was 16.3% compared to mean power and 
28.9% for the peak power.59 In the other study it was concluded that only large improvements 
(16–45%) can be detected when monitoring individual changes.60
Summarizing, other measurement instruments that measure muscle strength or endurance 
in children with CP also have high relative SDC values.
As the SDC value seems high irrespective of the measurement instrument used or population studied, 
one should question whether the current form of the SDC (as an absolute value valid for the total 
population) is appropriate for these types of measurement. Perhaps we should consider alternative 
ways to calculate the SDC, considering its intended use for interpreting change scores in individual 
patients.
Alternatives:
1) Calculate the SDC value as a percentage:
For example, when measuring the height of a person multiple times within a short period 
using a measuring rod, it is likely that the measurement error is about the same in all mea-
surements, independent of the height of the person. Changes in height are equally different/
easy to measure, independent of the individual, therefore an SDC value as an absolute number 
seems logical. However, when fixed/absolute values are used for measuring changes in muscle 
strength, a 5 N gain in muscle strength could be easier to achieve for a person who has a muscle 
strength of 100 N compared to a person who has a muscle strength of 2 N. After all, the person 
with the muscle strength of 100 N needs to gain 5% muscle strength, whereas the person with 
the muscle strength of 2 N needs to gain 250% muscle strength to achieve an increase of 5 N. 
As the muscle strength values of the children with USCP vary greatly, an increase equal to the 
SDC value is harder to meet for a child with low baseline muscle strength values compared to 
a child with higher values.
In this example it seems better to calculate the SDC value as a percentage so that it is equally 
difficult for every child to achieve an increase equal to the SDC value. This could be possible 
if the SEM was also calculated as a percentage, instead of an absolute value. However, until now, 
this has not been done.
2) Multiple measurements within one individual:
Alternatively, an SDC value could be determined for every child individually by taking multiple 
measurements before starting the intervention. The difference between the highest and the 
lowest muscle strength value at baseline can then be used to determine the child-specific 
SDC value. In this way, child-specific SDC values are available that can be used for evaluative 
purposes.
3) Divide the SDC by the square root of N:
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In the book Measurement in Medicine, it is indicated that for research with groups of patients the 
SDC value can be divided by the square root of the number of patients, N.61 This implies that 
in clinical research smaller changes are needed at group level to detect changes beyond the 
measurement error. This formula would also mean that for a large population it is always pos-
sible to measure an effect above the measurement error at group level. With this information, 
all measuring instruments will be useful in research with larger groups of children with USCP. 
However, in personal consultation with the COSMIN steering group, it was advised not to use 
this method. One of the authors declared that, in their opinion, the SDC value is only related to 
changes in individuals and not to changes in groups.
Further research on this topic is definitely needed. Until there is more clarity about alternative 
methods for calculating the SDC value, it is recommended that additional strength measure-
ment instruments are used. When multiple measurement instruments (preferably on different 
ICF levels) all show gains between the pre-/post-intervention measurements, there may be 
a higher probability that the intervention has a ‘real’ positive result.
Clinical implications
Who should be tested?
In children with USCP suspected of muscle weakness, the HHD, E-link and Cup and Box tasks are 
suitable in order to gain an impression of their muscle strength.
During muscle strength measurements, it is important that the child is able to fully cooperate. In 
the study by van Vulpen et al., lower reliability and higher SDC values were found in the age group 3–5 
years compared to children aged 6–10 years.52 Therefore, the chance of measurement error in younger 
children seems to be higher. It should also be kept in mind that strength training programmes are 
recommended no earlier than at the age of 7 years62 so it is not possible to set a ‘hard’ minimum age 
limit for measuring muscle strength.
Unfortunately, we were not able to research whether specific child characteristics related to 
USCP, such as the degree of spasticity or the Manual Ability Classification System (MACS) level, are 
related to the muscle strength of a child with USCP. As muscle weakness appears to be associated with 
impairment in the performance of UE activities.4–6 it is possible that children with USCP with less arm/
hand abilities have lower muscle strength compared to those with more arm/hand abilities. There are 
several classification methods to make a distinction in arm/hand abilities. In the Dutch CP guidelines, 
only the MACS is recommended for classification of the UE possibilities. Worldwide, the Bimanual Fine 
Motor Function (BFMF) classification is often used, which classifies fine motor function according to 
the child’s best ability (capacity) to grasp, hold and manipulate objects for each hand separately.
Because the MACS classifies bimanual possibilities, less can be said about the unimanual 
possibilities. Furthermore, because the muscle strength of the less-affected UE can also be affected, 
deviations in the less-affected UE can have a major impact on the MACS level. As a result, it is not 
self-evident that the MACS level is appropriate to use for stratification.
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Who should do the testing?
Our results showed that in most measurements the intraclass correlation coefficient (ICC) of the 
test-retest reliability is a fraction higher compared to the interrater reliability. However, differences 
in the ICC values for test-retest and interrater reliability are usually negligible and the 95% confidence 
intervals are largely overlapping. This is opposite to our expectations, as in interrater reliability mea-
surements (where multiple testers are involved) there seems to be a higher chance for measurement 
error. After all, differences between measurements as a result of differences in interpretation and 
execution of the measurement protocol are expected to be much higher when different raters are 
involved. This particular finding is propably due to the use of a standardized protocol and well-trained 
examiners, and can be regarded as an important indication for clinical practice that the use of both 
well-trained tester(s) and a clear testing protocol can reduce measurement error.
Around a single measurement there is always measurement error (SEM) but by taking several 
measurements the range between which the real value is located becomes narrower. To reduce the 
chance of measurement error, it is recommended that a standardized protocol be used and that the 
measurements are performed on different short successive moments (separate days) and measured 
multiple times within one measurement moment, taking the mean value of the measurements. This 
will minimize the likelihood that the differences in muscle strength are caused by differences in initial 
posture, specific influential child characteristics (e.g. fatigue), differences in placing of the measure-
ment instrument (the HHD) or differences in handling the measurement instrument (the E-link).
Clinical implications of the measurement instruments for 
discriminative purposes
As the reduced performance of the affected UE in children with USCP could be caused by several 
impairments in body functions, such as disturbances in both the passive and active range of motion, 
muscle tone, sensibility and muscle strength, task analyses and/or multiple tests need to be carried 
out to determine which factor has the largest contribution to the activity impairments.4–6
In most activities, not only is maximum muscle strength important but other components 
such as muscle strength generation, regulation and timing of the strength are also important in the 
execution of activities. If there is a suspicion that muscle strength is a limiting factor in activities, then 
all the different components have to be examined. Therefore, it is recommended that various strength 
measurement instruments are used, covering different strength components and different ICF levels.
To determine if the maximal UE muscle strength is reduced in children with USCP, both the 
HHD and E-link are excellent measurement instruments. However, to gather information about mus-
cle strength in a functional context (activity level of the ICF-CY), the Cup and Box tasks can be used.
As norm values for all these instruments are not yet available, it cannot be determined whether 
a child has ‘normal’ (functional) muscle strength. Overall, the less-affected UE in children with USCP is 
weaker compared to the norm of TD peers.63 A comparison of the affected UE with the less-affected 
UE, instead of with normative data, is therefore less appropriate to identify deficits in the less-affected 
UE: the critical clinical gaze of a professional will always be needed in the interpretation of measure-
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ment results. The development of norm values will be of great added value in interpreting the results 
in discriminative measurements. Furthermore, the lever-arm of the child could be included within the 
norm values, as the length of the lever-arm influences the outcome of the HHD and Cup and Box tasks.
Core set
Combining the results of different measurements of body functions (passive and active range of 
motion, muscle tone, sensibility) and constructs of muscle strength (grip and pinch: the E-link; arm: the 
HHD; functional strength: the Cup and Box tasks), but also tests to map muscle strength generation, 
regulation and timing of the strength, leads to a complete picture of the UE. With this knowledge, 
a more specific therapy programme can be tailored to the specific impairments of the individual child 
and, of course, to the goal of the child.
Clinical implications for evaluative purposes
Caution in the interpretation of changes in UE muscle strength measurements is needed. Based on our 
results, it is only possible to achieve a gain in muscle strength that is considered ‘real’ for the strongest 
children with USCP. By using the core set of instruments that measure muscle strength on multiple ICF 
levels, a little more certainty about changes in muscle strength as a result of training can be obtained. 
In addition, it is advisable to involve the child and the parents in formulating the expected progress 
of the therapy, by letting them determine the minimal change (on activity/participation level) that is 
needed to be clinically relevant (MIC). Also, specific measurements (e.g. Goal Attainment Scaling)64 
related to the goals (on activity/participation level of the ICF-CY) are needed for evaluative purposes.
When evaluating muscle strength over a longer period (years), it is advisable to include 
the lever-arm in the measurements. With this method the torque can be measured. This prevents 
measured differences in muscle strength between measurements that may not be due to changes 
in muscle strength but arise because the arm has grown longer.
Future research
 1. More research on the statistical alternatives for calculating the SDC value for field-based 
tests is needed. As displayed earlier in this discussion, it seems that in many field-based tests 
excellent ICC values are found but also high relative SDC values. Due to the high SDC values, 
most instruments seem unusable for evaluative purposes.
 2. It must be examined if, and by how much, the reduced maximum muscle strength of the 
less-affected UE is the cause of the reduced uni- and bimanual performances in children 
with USCP compared to TD children.
 3. More research on what causes the muscle weakness of the less-affected UE is needed. In 
addition, research on the possibilities and results of training the less-affected UE is needed 
to determine the best type of intervention.
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 4. It must be examined if a core set of UE (muscle strength) measurement instruments can be 
achieved. With the use of this core set, it should become clearer whether and where muscle 
weakness occurs and what the consequences are for the performance of activities. In eval-
uative measurements, with this core set it is easier to register changes in muscle strength. 
When multiple measurement instruments show gains between measurements, there may 
be a higher probability that the intervention has a ‘real’ positive result.
 5. More research about the norm values of the measurement instruments is needed. The 
development of norm values will be of great added value for the clinician in interpreting 
the results. These norm values must be based on TD children and ideally should include the 
lever-arm.
 6. Our research only focuses on children with USCP in the age group 7–12 years. It would be 
very interesting to find out if our results also apply to those who are younger than 7 years old 
and to those aged 13–18 years.
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Valorisation Addendum
In this dissertation, valorisation is considered as “the process of creating value from knowledge, 
by making knowledge suitable and/or available for social (and/or economic) use and (by making it 
suitable) for translation into competing products, services, processes and new activities” (definition 
taken from the report of the National Valorisation Committee, Waardevol: Indicatoren voor Valorisatie 
[Valuable: Indicators for valorisation] (2011) The Hague: Rathenau Institute, p. 8).
In this valorisation-addendum the following topics will be addressed:
 1. social relevance of research results;
 2. target groups to whom research results are of interest;
 3. products/activities in which research results can be applied and formalized;
 4. the extent to which research results can be called innovative;
 5. how the valorisation plan will be implemented.
1. Social relevance of research results
Worldwide, CP is the most common motor disorder in childhood, with a prevalence in Europe of about 
1.8–2.1 per 1,000 live births. Within the Dutch pediatric rehabilitation, CP is the largest group ( > 32%) 
receiving interdisciplinary pediatric rehabilitation treatments, resulting in high healthcare costs. 
Healthcare costs in Dutch pediatric rehabilitation in 2018 amounted to approximately 146 million euros.
Approximately 30% of all children with CP are diagnosed with unilateral spastic cerebral palsy 
(USCP). Muscle weakness of the affected upper extremity (UE) is one of the main characteristics of 
a child with USCP. Measuring muscle strength is a common activity in daily practice for most clini-
cians working with children with USCP in order to determine whether muscle strength weakness is 
present (discriminative) or whether muscle strength training has been effective (evaluative). In order 
to be able to measure changes in muscle strength, one needs to know the extent to which varia-
tions in measurement results occur between repeated measurements. This so-called measurement 
error may have several causes: the measurement instrument itself, the examiner(s) performing the 
measurement, the patient undergoing the measurement and the circumstances under which the 
measurement is performed.
This dissertation gives more insight into the (im)possibilities of measuring UE muscle strength 
in children with USCP in clinical practice.
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Regarding the less-affected UE, only two studies had investigated muscle strength of the 
less-affected hand in children with USCP, with opposite conclusions. As it was not clear whether mus-
cle weakness is a unilateral problem or whether both UEs have muscle weakness, we also researched 
the muscle strength of both UEs in children with USCP. This dissertation provides new insights into UE 
muscle strength in children with USCP (both affected and less-affected).
2. Target groups to whom research results are of interest
The results presented in this thesis are of interest to clinicians and researchers working with children 
with USCP. Our results can be used to 1) further optimize diagnostics and therapy (including the 
less-affected UE) and 2) to improve the use and interpretation of strength measurements for evalua-
tive purposes.
Moreover, information about the Standard Error of the Measurement (SEM), Smallest Detect-
able Change (SDC), and the introduction of two new functional UE muscle strength measurement are 
valuable to the clinicians.
As the SDC values seem highly irrespective of the measurement instrument used or population 
studied, we advise that alternative ways to calculate the SDC should be considered. Therefore, the 
discussion of the dissertation is also interesting for statisticians and/or clinical epidemiologists who 
are interested in the smallest detectable change of measurement instruments.
To a lesser extent, policy makers can use our results to determine which interventions can be 
included during the development or update of clinical guidelines. Finally, this indirectly concerns 
health insurers because they can decide which (effective) muscle strength training intervention is 
reimbursed. and which is not.
3. Products/activities in which research results will be 
applied and formalised
Our measurement protocol is freely available and a large part of the measurement protocol has 
already been published as an appendix of the paper presented in chapter 4. If needed, we can train 
therapists in the (right) use and interpretation of measurement instruments.
We have also disseminated our results by presentations and mini symposiums at national 
and international conferences. After finishing this PhD, the dissemination of the results at national 
and international conferences will continue and a one-day symposium will be organised by Revant, 
Rehabilitation Centre Breda and Adelante Kenniscentrum in Hoensbroek, in collaboration with the 
Department of Rehabilitation Medicine (Care and Public Health Research Institute (CAPHRI)) of Maas-
tricht University. The symposium is intended for clinicians and researchers.
As far as the cup and box tasks are concerned, we have chosen to use commonly available 
objects, so that they can easily be used by every clinician.
Recently, a computerised version of the cup and box tasks has been developed (activity Daily 
Life test and training Device-ADL-TTD), which can be used in research but also for training UE muscle 
strength. The ADL-TTD is also the first measuring instrument in which muscle strength during multiple 
(long lasting) dynamic functional tasks can be measured by a computer. Clinimetric properties of the 
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ADL-TTD are currently being researched. If the product is usable in clinical practice and clinimetric 
properties are acceptable, the product will become commercially available (under the license of 
Umaco b.v./ Procare b.v.)
4. The extent to which research results can be called 
innovative
Our study was the first study in which clinimetric properties of UE measurement instruments for 
children with USCP were researched in a study of good methodological quality as suggested by the 
COSMIN.
Although a few functional UE muscle strength measurement instruments are available, the Cup 
and Box tasks are the first functional muscle strength measurements in which the ability to maintain 
the strength in a sustained contraction can be measured.
Another innovation is that we showed that in children with USCP, muscle weakness is present 
in both UEs. As a result, measurement of both hands separately must be done in the diagnostic phase, 
and a bimanual strength measurement must be added. Besides, in case of muscle weakness of the 
less-affected UE, bimanual activity training seems to be more valuable than just providing unimanual 
training of the affected UE.
To our knowledge, we are the first research group to criticise the calculation of the smallest 
detectable change in upper extremity muscle strength measurements in children with USCP. Alterna-
tive methods should be considered.
5. How the valorisation plan will be implemented
As our research did not contain any intervention or product development, less can be said about the 
implementation of the valorisation plan. Information on how the knowledge/results are disseminated 
has already been mentioned in paragraph 3 of this addendum. Additionally, within our research net-
work, the results have been disseminated with the message that:
 — the measurement instruments studied are useful for clinical practice,
 — measure the muscle strength in both arms
 — measure different constructs of muscle strength, such as peak and endurance strength and 
certainly functional strength
 — have the measurements performed by trained therapists
 — measure multiple times, as described in our standardized measurement protocol, and
 — use the measurement instruments we have researched.
What we can and will implement, is the use of the measurement instruments in regular rehabil-
itation and in highly intensive existing UE therapy camps for children with USCP. The findings regard-
ing the muscle weakness of the less-affected UE will be communicated to the project leaders of the 
UE training camps and we will discuss with them what possibilities there are to pay more attention 
to the less affected UE. The “Handen in elkaar” platform and the CP-Net organisation will be invited to 
spread the knowledge in the Netherlands.
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Regarding the calculation of the SDC, presented in chapter 6, we made an appeal that future 
research should focus on alternative ways to calculate the SDC. In the near future we will contact the 
members of the COSMIN team to discuss our results and recommendations regarding this topic to 
facilitate this research. 
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“CP describes a group of permanent disorders of the development of movement and posture, causing 
activity limitation, that are attributed to non-progressive disturbances that occurred in the developing 
fetal or infant brain. The motor disorders of CP are often accompanied by disturbances of sensation, 
perception, cognition, communication, behavior, by epilepsy, and by secondary musculoskeletal 
problems.” By far the largest group ( > 85%) consists of children with spastic CP. This group can be 
divided into bilateral and unilateral spastic CP. Overall, almost 30% of all children with CP are diagnosed 
with unilateral spastic cerebral palsy (USCP). USCP is characterized by motor impairments lateralized 
to one side of the body, resulting in an “affected” and a “non-affected” body side.
Children with USCP are typically more limited in manual ability than in gross motor function. 
They usually have difficulty with grasping, reaching, releasing, and manipulating objects with the 
affected upper extremity (UE), limiting their ability to execute activities of daily living and restricting 
their independence and participation. About 60% of the children between the age of 4- and 16-years 
experiences problems with their arm-hand function during daily activities predominantly caused 
by impairments in muscle function.
Muscle weakness appears to be one of the most important causes of impairment in perfor-
mance of UE activities.
Measuring muscle strength is a common activity in daily practice for most clinicians working 
with children with USCP in order to determine whether muscle strength weakness is present (discrim-
inative) or whether muscle strength training has been effective (evaluative). In order to make infer-
ences about muscle strength, either in clinical practice or in research, strength has to be measured 
with an instrument that has sound clinimetric properties. To know the extent to which the strength 
measurement instrument is suitable for discriminative and evaluative purposes in clinical practice, the 
clinimetric properties “reliability” and “responsiveness” of the instrument need to be known. Reliability 
indicates the degree to which the measurement is free from measurement error. With an Intraclass 
Correlation Coefficient (ICC) value it is possible to determine whether the measurement instrument 
is suitable for discriminative purposes. The related Standard Error of Measurement (SEM) is a measure 
of how far apart the outcomes of repeated measurements are; it is the standard deviation around 
a single measurement.
Responsiveness indicates the ability of a measurement instrument to detect changes over time 
in the construct being measured. For the interpretation of a change in score, the smallest detectable 
change (SDC) and the minimally important change (MIC) are important. With the SDC, it can be deter-
mined whether the difference between two (evaluative) measurements can be distinguished from 
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a measurement error. In order to know whether a change score is also clinically important, the MIC 
is considered the most important value. The MIC is the smallest change score in the construct to be 
measured that patients, clinicians or relevant others perceive as important.
The quality of each clinimetric property can be rated as positive, negative or indeterminate, 
according to internationally accepted criteria. In addition to the value of the clinimetric property, it is 
important that the research of the determination of the clinimetric property is conducted in a study 
of (at least) good methodological quality.
Four out of five studies presented in this thesis focus on the clinimetric properties of various UE 
strength measuring instruments for children with USCP and on the interpretation of their outcomes, 
with the intention of clarifying how useful these measurement instruments actually are in clinical 
practice. The fifth study focuses on the muscle strength of the non-affected UE in children with USCP 
because it is not clear whether muscle weakness is a unilateral problem or whether the ‘non-affected’ 
UE is also affected.
The first step was to obtain a detailed overview of the existing UE muscle strength tests for 
children with USCP. Therefore we performed a systematic review in which the reported clinimetric 
properties were derived from the studies and also the methodological quality of the studies was 
determined. A data-synthesis of both aspects was performed to determine which measurement 
instruments are useable in clinical practice. The systematic review is presented in Chapter two. In the 
few (a total of seven) studies studying a total of six measurement instruments for measuring upper 
extremity strength, only test-retest, intrarater, and interrater reliability were investigated in a select 
group of age ranges, Manual Ability Classification System (MACS) levels, and Gross Motor Function 
Classification System (GMFCS) levels. No conclusions can be made regarding the responsiveness, the 
SDC or SEM. Furthermore, it is not clear whether all measurement instruments specifically measure 
muscle strength, as validity has not been investigated. Although the assessed clinimetric properties 
for most measurement instruments were rated positive, the methodological quality of the studies 
was mostly poor. As a result, the found clinimetric properties have hardly any scientific value. Three 
measurement instruments can be used in clinical practice. First; to measure grip strength, it is rec-
ommended to use the Jamar dynamometer. Second; for measuring other upper extremity muscle 
groups, it is recommended to use the Hand Held Dynamometry (HHD). Third; manual muscle testing 
can be used when measuring the “total upper extremity” or wrist strength in children with CP who 
have very limited muscle strength ((≤ grade 3).
Based on these results, only two instruments (HHD and Jamar) were identified as potentially use-
ful UE muscle strength measurement instruments. Next, we performed a study to determine test-retest 
and interrater reliability of these measurement instruments in children with USCP, in a study designed 
using the guidelines of the COSMIN consortium. The results are presented in Chapter three. Instead of 
the Jamar dynamometer, we used a digitalized version (E-link) of this measurement instrument.
Our results showed that almost all arm/hand strength measurements (performed with the HHD 
and E-link) have excellent test–retest reliability and excellent interrater reliability in children with USCP, 
aged 7–12 years. Only the interrater reliability of the elbow flexion of the affected UE was classified as 
“good”, meaning there was more variability in the performance of this measurement. We concluded 
that the HDD and E-link system are usable measurement instruments in cross-sectional measure-
ments of UE muscle strength in children with USCP. Because there is no clear information available 
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on how much improvement a child with USCP can achieve after a strength-training program, it is not 
clear if both instruments are usable for measuring changes in UE muscle strength within one person, 
especially if a child with USCP has low muscle strength.
In most daily life manual activities, e.g. during carrying/moving a heavy box, not only a certain 
amount of muscle strength is required, but also the ability to maintain/regulate that strength for a cer-
tain time. This ability is called functional strength and needs to be measured during the performance 
of the specific task. As there were no existing measurement instruments available which measure 
UE strength in the context of functional activities, two specific functional muscle strength tests were 
developed. These tests measure unimanual and bimanual sustained contractions, i.e., the “Cup-Task” 
for determining maximal functional unimanual UE strength and the “Box-Task” for determining maxi-
mal functional bimanual UE strength. In both tests, a combination of functional grip and arm strength 
is measured by lifting the Cup or Box, which must be sustained for five seconds.
We determined the reliability and validity of these two new functional muscle strength mea-
surement instruments in children with USCP, also following the guidelines of the COSMIN consortium. 
The results are presented in Chapter four. We concluded that the Cup-Task and Box-Task are reliable 
and valid measurement instruments for measuring functional hand and upper extremity muscle 
strength in children with USCP who can perform such tasks. However, most of the children with USCP 
and MACS level III will not be able to perform the Cup-Task with the affected UE. Due to the lack of 
information about the possibilities in gaining functional muscle strength, the same conclusion as with 
the HHD and E-link was drawn regarding their evaluative use, namely that it is not clear whether both 
instruments are usable for measuring changes in UE muscle strength within one person, especially 
if a child with USCP has low muscle strength.
As only two studies compared the non-affected UE muscle strength of children with USCP and 
children with typically development (TD), and these studies had opposite conclusions as to whether 
muscle weakness only occurs in the affected UE, we performed a study to compare the isometric mus-
cle strength (measured with the HHD and E-link) of the affected and non-affected UE of children with 
USCP to the isometric muscle strength of children with TD. The results are presented in Chapter five.
In the affected UE (non-preferred UE), for all measures the children with USCP produced statis-
tically significantly lower muscle strength values compared to children with TD. Our study confirms 
the hypothesis that children with USCP can generate less muscle strength with the non-preferred side 
compared to children with TD. However, it is remarkable that the percentage difference in muscle 
strength is less in the proximal UE muscle groups compared to the distal UE muscle groups. A possible 
explanation is that the severity of hand function is closely related to the integrity and organization of 
direct corticospinal projections to the hand muscles. A second explanation might be that because 
most children with USCP only use the non-preferred UE to support the preferred UE, the proximal 
muscle groups may be used more compared to the distal (fine motor) muscle groups.
Muscle weakness of the non-affected UE (preferred UE) of children with USCP seems to go 
beyond impairments in the hand. It was striking that the muscle strength of the elbow flexion and 
extension in the younger age groups is higher in children with USCP than in children with TD. In 
the older age groups, this difference between groups is reversed. A possible explanation could be 
the intensive (bimanual) training that (most) of the participating children with USCP received at the 
younger age. More research to explain this result is needed.
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An important difference between the study we have performed and the other studies that 
researched the muscle strength of the non-affected UE, is that we used a different measurement 
instrument to measure grip strength and small differences in muscle strength are more likely to be 
picked up by the E-Link system.
An important recommendation based on our results is that when uni- or bimanual ability lim-
itations are present, investigation of muscle strength in the non-affected UE should be part of the 
assessment.
In the last study, we present a critical perspective on how to interpret changes in UE muscle 
in children with USCP strength, measured with the HHD and E-link, taking an expert-based MIC and 
the measurement error of the measurement instruments into account. The critical perspective is 
presented in Chapter six.
We concluded that in clinical practice, for most children with USCP it is possible to measure 
clinically important changes in muscle strength in the affected UE by means of the HHD and E-link, 
However, due to the high SDC values, only in those with a high baseline level of muscle strength, 
the clinically important changes can also be considered “real” changes, i.e. higher than measurement 
error. Hence, it is only possible to achieve a gain in muscle strength that is considered “real” for 
a small proportion of the children with USCP. Great caution in the interpretation of the change score 
is recommended.
Regarding the less affected UE, only in some children (and in some measurements) the clini-
cally important changes can also be considered “real” changes. For the majority of the children with 
USCP, the important changes cannot be distinguished from measurement error. Because of the lack 
of information on the muscle strength gain possibilities of the less affected UE, no firm conclusions 
can be drawn on whether it is possible to measure clinically important and/or statistically significant 
changes within one child.
To reduce the chance of measurement error, we recommend to use a standardized protocol, 
to perform the measurements by the same assessor and to measure multiple times within one mea-
surement moment, taking the mean value of the measurements. This minimize the likelihood that 
the differences in muscle strength are caused by differences in initial posture, differences in placing of 
the measurement instrument (HHD) or differences in handling the measurement instrument (E-link).
Chapter seven contains the general discussion, in which the main results are evaluated. Also, 
the methodological considerations are discussed and implications for clinical practice and future 
research are presented.
As the HHD, E-link, Cup-and box task all have a large SDC-value, we also discussed whether the 
SDC value, calculated/determined according to the current method, is suitable for muscle strength 
measurement instruments used in a (heterogeneous) rehabilitation population. Therefore, we made 
an overview of the SDC values of the HHD and E-link in other populations, and of the SDC values of 
other measurement instruments which measure muscle strength in children with USCP. The results 
show that the SDC value seems high irrespective of the measurement instrument used or population 
studied. Alternative ways to calculate the SDC should be considered, considering its intended use 
for interpreting change scores in individual patients. Suggested alternatives are: calculate the SDC 
value as a percentage; or take multiple measurements within one individual and use the difference 
between the highest and the lowest muscle strength value to determine the child-specific SDC value.
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Further research on this topic is definitely needed. Until there is more clarity about alternative 
methods for calculating the SDC value, it is recommended that additional strength measurement 
instruments are used. When multiple measurement instruments (preferably on different ICF levels) 
all show gains between the pre-/post-intervention measurements, there may be a higher probability 
that the intervention has a ‘real’ positive result.
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Nederlandse samenvatting 
(Dutch summary)
"Cerebrale Parese (CP) beschrijft een groep van permanente stoornissen in de ontwikkeling van 
beweging en houding, waardoor beperking in activiteiten optreedt, die wordt toegeschreven aan 
niet-progressieve stoornissen, die zich hebben voorgedaan in de zich ontwikkelende foetale- of 
zuigelingenhersenen. De motorische stoornissen van CP gaan vaak gepaard met stoornissen van 
gevoel, waarneming, cognitie, communicatie, gedrag, door epilepsie en secundaire spier- en skelet-
problemen."
Veruit de grootste groep ( > 85%) bestaat uit kinderen met spastische CP. Deze groep kan worden 
onderverdeeld in bilaterale (tweezijdige) en unilaterale (eenzijdige) spastische CP. Gemiddeld geno-
men is bijna 30% van alle kinderen met CP gediagnosticeerd met unilaterale spastische cerebrale 
parese (USCP). USCP wordt gekenmerkt door motorische stoornissen aan een zijde van het lichaam, 
wat resulteert in een "aangedane" en een "niet-aangedane" lichaamszijde.
Kinderen met USCP zijn meestal meer beperkt in fijn motorische arm/handvaardigheden dan 
in grof-motorische activiteiten. Ze hebben meestal moeite met het grijpen, reiken, het vasthouden 
en manipuleren van objecten met de “aangedane” bovenste extremiteit (BE). Hierdoor wordt hun 
vermogen om activiteiten van het dagelijks leven uit te voeren beperkt en hun onafhankelijkheid en 
participatie belemmerd. Ongeveer 60% van de kinderen tussen 4 en 16 jaar ondervindt problemen 
met hun arm/handfunctie tijdens dagelijkse activiteiten, voornamelijk veroorzaakt door beperkingen 
in de spierfunctie. Spierzwakte lijkt een van de belangrijkste oorzaken van de beperkingen in de uit-
voering van BE-activiteiten.
Het meten van spierkracht is een veel voorkomende activiteit in de dagelijkse praktijk voor 
de meeste clinici die werken met kinderen met USCP. Enerzijds wordt spierkracht gemeten om te 
bepalen of spierzwakte aanwezig is (discriminerend), anderzijds om te onderzoeken of een interven-
tie effectief is geweest (evaluatief ). Om conclusies te kunnen trekken over spierkracht, hetzij in de 
klinische praktijk of in onderzoek, moet kracht worden gemeten met een instrument dat goede 
klinimetrische eigenschappen heeft. Om te weten in hoeverre het krachtmeetinstrument geschikt 
is voor discriminerende en evaluatieve doeleinden in de klinische praktijk, moeten de klinimetrische 
eigenschappen "betrouwbaarheid" en "responsiviteit" van het instrument bekend zijn. Betrouwbaar-
heid geeft aan in welke mate de meting vrij is van meetfouten. Met een Intraclass Correlatiecoëfficiënt 
(ICC) is het mogelijk om te bepalen of het meetinstrument geschikt is voor discriminerende doelein-
den. De bijbehorende standaardmeetfout (SEM) is een maat voor hoe ver de resultaten van herhaalde 
metingen zijn; het is de standaarddeviatie rond een enkele meting.
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Responsiviteit geeft het vermogen van een meetinstrument aan om veranderingen in de tijd te 
detecteren. Voor de interpretatie van een verandering in score is de kleinste detecteerbare verande-
ring (smallest detectable change; SDC) en de minimaal belangrijke verandering (minimal important 
change; MIC) belangrijk. Met de SDC kan worden bepaald of het verschil tussen twee (evaluatieve) 
metingen kan worden onderscheiden van een meetfout. Om te weten of een veranderingsscore ook 
klinisch belangrijk is, wordt de MIC beschouwd als de belangrijkste waarde. De MIC is de kleinste 
veranderingsscore die patiënten, clinici of relevante anderen als belangrijk ervaren.
Aan de hand van internationaal aanvaarde criteria voor kwaliteitsbeoordeling kan de kwaliteit 
van elke klinimetrische eigenschap worden beoordeeld als positief, negatief of onbekend. Naast de 
kwaliteit van de klinimetrische eigenschap is het belangrijk dat het onderzoek naar de bepaling van 
de klinimetrische eigenschap wordt uitgevoerd in een studie van (ten minste) goede methodologi-
sche kwaliteit.
Vier van de vijf studies die in dit proefschrift worden gepresenteerd, richten zich op de klinime-
trische eigenschappen van verschillende BE-spierkrachtmeetinstrumenten voor kinderen met USCP 
en op de interpretatie van hun uitkomsten, met de bedoeling te verduidelijken hoe bruikbaar deze 
meetinstrumenten eigenlijk zijn in de klinische praktijk. De vijfde studie richt zich op de spierkracht 
van de “niet-aangedane” BE bij kinderen met USCP, omdat het niet duidelijk is of spierzwakte een 
eenzijdig probleem is of dat spierzwakte ook in de 'niet-aangedane' BE aanwezig is.
De eerste stap was het verkrijgen van een gedetailleerd overzicht van de bestaande meet-
instrumenten voor het meten van de spierkracht in de BE bij kinderen met USCP. Daarom hebben 
we een systematische review uitgevoerd waarbij de gerapporteerde klinimetrische eigenschappen 
werden afgeleid van de onderzoeken. Tevens werd ook de methodologische kwaliteit van de stu-
dies bepaald. Een datasynthese van beide aspecten werd uitgevoerd om te bepalen welke meet-
instrumenten bruikbaar zijn in de klinische praktijk. De systematische review wordt gepresenteerd 
in hoofdstuk twee.
In een beperkt aantal (in totaal zeven) studies werden in totaal zes meetinstrumenten voor het 
meten van de BE-spierkracht bestudeerd. In deze studies werden alleen test-hertest betrouwbaarheid, 
intrabeoordelaars- en interbeoordelaarsbetrouwbaarheid onderzocht. De populaties die in de studies 
werden beschreven betroffen ook nog eens een selecte groep wat betreft leeftijd, MACS-niveaus 
(Manual Ability Classification System) enGross Motor Function Classification System (GMFCS) niveaus. 
Er konden geen conclusies worden getrokken over de responsiviteit, de SDC of SEM. Bovendien 
was het niet duidelijk of alle meetinstrumenten specifiek de spierkracht meten, omdat de validiteit 
niet is onderzocht. Hoewel de klinimetrische eigenschappen voor de meeste meetinstrumenten 
positief werden beoordeeld, was de methodologische kwaliteit van de studies meestal slecht. Als 
gevolg hiervan hebben de gevonden klinimetrische eigenschappen nauwelijks wetenschappelijke 
waarde. In de klinische praktijk kunnen drie meetinstrumenten worden gebruikt. Ten eerste, de Jamar 
dynamometer om de grijpkracht te meten. Ten tweede, de Hand Held Dynamometer (HHD) voor het 
meten van andere spiergroepen in de BE. Ten derde, handmatige spiertesten voor het meten van de 
"totale bovenste extremiteit" of polssterkte bij kinderen met CP die een zeer beperkte spierkracht 
hebben (≤ graad 3).
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Op basis van deze resultaten werden slechts twee instrumenten (HHD en Jamar) geïdentifi-
ceerd als potentieel nuttige BE-spierkrachtmeetinstrumenten. Vervolgens hebben we een studie 
uitgevoerd om de test-hertest betrouwbaarheid en interbeoordelaarsbetrouwbaarheid van deze 
meetinstrumenten bij kinderen met USCP te bepalen, in een studie van goede methodologische 
kwaliteit (volgens de richtlijnen van het COSMIN-consortium). De resultaten worden gepresenteerd 
in hoofdstuk drie. In plaats van de Jamar dynamometer gebruikten we een gedigitaliseerde versie 
(E-link) van dit meetinstrument.
Onze resultaten toonden aan dat bijna alle arm/hand spierkracht metingen (uitgevoerd met de 
HHD en E-link) een uitstekende test-hertest betrouwbaarheid en uitstekende interbeoordelaarsbe-
trouwbaarheid hebben bij kinderen met USCP, leeftijd 7–12 jaar. Alleen de interbeoordelaarsbetrouw-
baarheid van de elleboog-flexie van de aangedane BE werd geclassificeerd als "goed", wat betekent 
dat er meer variabiliteit is tussen metingen. We concludeerden dat het HDD- en E-linksysteem bruik-
bare meetinstrumenten zijn voor discriminerende BE-spierkracht metingen bij kinderen met USCP. 
Omdat er geen duidelijke informatie beschikbaar is over hoeveel verbetering een kind met USCP kan 
bereiken na een krachttrainingsprogramma, is het niet duidelijk of beide instrumenten bruikbaar zijn 
voor het meten van veranderingen in BE-spierkracht binnen één persoon, vooral als een kind met 
USCP een lage spierkracht heeft.
In de meeste dagelijkse activiteiten, bijvoorbeeld tijdens het dragen of verplaatsen van een 
zware doos, is niet alleen een bepaalde hoeveelheid spierkracht vereist, maar ook de mogelijkheid om 
die kracht gedurende een bepaalde tijd te behouden/te reguleren. Dit vermogen wordt functionele 
spierkracht genoemd en moet worden gemeten tijdens de uitvoering van de specifieke taak. Aan-
gezien geen bestaande meetinstrumenten beschikbaar waren die de BE-spierkracht in het kader van 
functionele activiteiten meten, werden twee specifieke functionele spierkracht testen ontwikkeld. 
Deze tests meten unimanuele en bimanuele functionele spierkracht, d.w.z. de "maatbeker-taak" voor 
het bepalen van maximale functionele unimanual BE-spierkrachten de "krat-taak" voor het bepalen 
van maximale functionele bimanuale BE-spierkracht. In beide tests wordt een combinatie van functi-
onele hand- en armspierkracht gemeten door de maatbeker of krat op te tillen, en deze gedurende 
vijf seconden in een bepaalde positie te houden.
We hebben de betrouwbaarheid en validiteit van deze twee nieuwe functionele spierkracht-
testen bepaald bij kinderen met USCP, volgens de richtlijnen van het COSMIN-consortium. De 
resultaten worden gepresenteerd in hoofdstuk vier. We concludeerden dat de maatbeker-taak en 
krat-taak betrouwbare en valide meetinstrumenten zijn voor het meten van functionele hand- en 
armspierkracht bij kinderen met USCP die dergelijke taken kunnen uitvoeren. Echter, de meeste van 
de kinderen met USCP en MACS niveau-III zullen niet in staat zijn om de maatbeker-taak uit te voeren 
met de aangedane BE. Vanwege het gebrek aan informatie over mogelijke resultaten van functionele 
spierkracht training, werd dezelfde conclusie getrokken als bij de HHD en E-link met betrekking tot 
hun evaluatief gebruik, namelijk dat het niet duidelijk is of beide instrumenten bruikbaar zijn voor het 
meten van veranderingen in BE (functionele) spierkracht binnen één persoon, vooral als een kind met 
USCP een lage spierkracht heeft.
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Aangezien slechts twee studies de niet-aangedane BE-spierkracht van kinderen met USCP en 
typisch ontwikkelende (TD) kinderen hebben vergeleken, en deze studies tegengestelde conclusies 
hadden over de vraag of spierzwakte alleen optreedt in de aangedane BE, voerden we een studie uit 
om de isometrische spierkracht (gemeten met de HHD en E-link) van de aangedane en niet-aange-
dane BE van kinderen met USCP te vergelijken met de isometrische spierkracht van kinderen met TD. 
De resultaten worden gepresenteerd in hoofdstuk vijf.
Voor wat betreft de aangedane BE hadden kinderen met USCP in alle spiergroepen statistisch 
aanzienlijk minder spierkracht in vergelijking met niet-voorkeurs BE van kinderen met TD. Onze studie 
bevestigt de hypothese dat kinderen met USCP minder spierkracht kunnen genereren met de aange-
dane BE in vergelijking met kinderen met TD. Het is echter opmerkelijk dat het procentuele verschil 
in spierkracht minder is in de proximale BE-spiergroepen in vergelijking met de distale BE-spiergroe-
pen. Een mogelijke verklaring is dat de ernst van de handfunctie nauw verwant is aan de integriteit 
en organisatie van directe corticospinale projecties van de handspieren. Een tweede verklaring zou 
kunnen zijn dat, omdat de meeste kinderen met USCP alleen gebruik maken van de aangedane BE 
ter ondersteuning van de niet- aangedane BE, de proximale spiergroepen meer worden gebruikt 
in vergelijking met de distale (fijne motorische) spiergroepen.
Ook in de niet-aangedane BE van kinderen met USCP is spierzwakte aanwezig en deze lijkt in de 
hele niet-aangedane BE voor te komen (in vergelijking met de voorkeurs BE van kinderen met TD). Het 
is dus beter om te spreken van een “minder-aangedane” BE. Het was opvallend dat kinderen met USCP 
in de jongere leeftijdsgroepen sterker zijn in de elleboogflexie en -extensie in vergelijking met kinde-
ren met TD. In de oudere leeftijdsgroepen is dit verschil tussen groepen omgekeerd. Een mogelijke 
verklaring zou de intensieve (bimanuele) training kunnen zijn die (de meeste) van de deelnemende 
kinderen met USCP op jongere leeftijd kregen. Om dit resultaat te verklaren, is meer onderzoek nodig.
Een belangrijk verschil tussen de studie die wij hebben uitgevoerd en de andere studies die de 
spierkracht van de “minder-aangedane” BE hebben onderzocht, is dat we een ander meetinstrument 
gebruikten om grijpkracht te meten en kleine verschillen eerder zullen worden opgepikt door het 
door ons gebruikte E-Link-systeem.
Een belangrijke aanbeveling op basis van onze resultaten is dat wanneer uni- of bimanuele 
beperkingen aanwezig zijn, moet het in kaart brengen van de “minder-aangedane” BE-spierkracht 
deel uitmaken van het onderzoek.
In de laatste studie presenteren we een andere kijk op het interpreteren van veranderingen 
in BE-spierkracht bij kinderen met USCP, gemeten met de HHD en E-link, rekening houdend met een 
MIC en de meetfout van de meetinstrumenten. Dit perspectief wordt gepresenteerd in hoofdstuk zes.
We concludeerden dat in de klinische praktijk, bij de meeste kinderen met USCP het mogelijk is 
om klinisch belangrijke veranderingen in spierkracht in de aangedane BE te meten door middel van 
de HHD en E-link. Echter, als gevolg van de hoge SDC-waarden, kunnen alleen bij kinderen met veel 
spierkracht de klinisch belangrijke veranderingen ook worden beschouwd als "echte" veranderingen, 
d.w.z. niet veroorzaakt door meetfouten. Vandaar dat een ‘echte’ winst in spierkracht alleen bereikbaar 
is voor een klein deel van de kinderen met USCP. Grote voorzichtigheid bij de interpretatie van een 
veranderingsscore is noodzakelijk.
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Met betrekking tot de “minder-aangedane” BE, kunnen alleen bij sommige kinderen (en in som-
mige metingen) de klinisch belangrijke veranderingen ook worden beschouwd als "echte" verande-
ringen. Voor de meerderheid van de kinderen met USCP kunnen de belangrijke veranderingen niet 
van metingsfout worden onderscheiden. Door het gebrek aan informatie over de mogelijkheden van 
spierkrachtwinst van de “minder-aangedane” BE als gevolg van training, kunnen geen harde conclu-
sies worden getrokken met betrekking tot de vraag of het mogelijk is om klinisch belangrijke en/of 
statistisch significante veranderingen te meten binnen een kind.
Om de kans op meetfouten te verkleinen, raden we aan om ons gestandaardiseerde meetpro-
tocol te gebruiken, de metingen door dezelfde geschoolde beoordelaar uit te laten voeren en meer-
dere keren binnen één meetmoment te meten, waarbij de gemiddelde waarde van de metingen 
wordt gemeten. Dit minimaliseert de kans dat de verschillen in spierkracht worden veroorzaakt door 
verschillen in uitgangshouding, verschillen in plaatsing van het meetinstrument (HHD) of verschillen 
in de hantering van het meetinstrument (E-link).
Hoofdstuk zeven bevat de algemene discussie, waarin de belangrijkste resultaten worden 
geëvalueerd. Ook worden de methodologische overwegingen besproken en implicaties voor de 
klinische praktijk en toekomstig onderzoek gepresenteerd.
Aangezien de HHD, E-link, maatbeker-taak en krat-taak allemaal een grote SDC-waarde hebben, 
hebben we ook bediscussieerd of de SDC-waarde, berekend/bepaald volgens de huidige methode, 
geschikt is voor spierkracht-meetinstrumenten gebruikt in een (heterogene) revalidatie populatie. 
Daarom hebben we een overzicht gemaakt van de SDC-waarden van de HHD en E-link in andere 
populaties, en van de SDC-waarden van andere meetinstrumenten die spierkracht meten bij kinderen 
met USCP. De resultaten tonen aan dat de SDC-waarde hoog is, ongeacht het gebruikte meetinstru-
ment of de onderzochte populatie. Alternatieve manieren om de SDC-waarde te berekenen moeten 
worden overwogen. Voorgestelde alternatieven zijn: bereken de SDC-waarde als percentage; of neem 
meerdere metingen binnen één persoon en gebruik het verschil tussen de hoogste en de laagste 
spierkrachtwaarde om de kindspecifieke SDC-waarde te bepalen.
Verder onderzoek over dit onderwerp is zeker nodig. Totdat er meer duidelijkheid is over 
alternatieve methoden voor het berekenen van de SDC-waarde, wordt aanbevolen om extra spier-
kracht-meetinstrumenten te gebruiken. Wanneer meerdere meetinstrumenten (bij voorkeur op 
verschillende ICF-CY niveaus) allemaal winst laten zien tussen de pre-/post-interventiemetingen, is 
de kans groter dat de interventie een “reëel” positief resultaat heeft.
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